Randevu almak artık daha da kolay!
incele
X
Nevrez Koylan

Prof.

Nevrez Koylan

He has been working as an internal medicine specialist and cardiologist at Anadolu Medical Center since 2011.

  • Clinic Address
    Ataşehir
  • Contact information
    Call Center 44 44 276 44 44 276
Contact Doctor
  • Biography

    Prof. Nevrez Koylan, graduated from Istanbul University, Istanbul Medical School. He completed his specialty education again at Istanbul University, Istanbul Medical School, Internal Medicine Department.  Prof. Koylan who is married and has a daughter, respectively, served as internal medicine specialist at Iğdır State Hospital, specialist research assistant at Istanbul University, Istanbul Medical School, Internal Medicine Department, and lecturer at Cardiology Department.   Prof. Koylan has been serving as an internal medicine specialist and cardiologist at Anadolu Medical Center since 2011. 
  • Education

    University 

    Istanbul University Istanbul Medical School, Istanbul 1981 

    Specialty education 

    Istanbul University Istanbul Medical School, Internal Medicine Department, Istanbul 1986 

    Associate Professor 

    1990

    Professor 

    1996

  • Institutional Memberships

    American College of Cardiology (FACC)
    European Society of Cardiology (FESC)
    European Society of Hypertension 
    International Atherosclerosis Society 
    European Atherosclerosis Society 
    European Association on Cardiovascular Prevention and Rehabilitation (EACPR) 
    European Heart Failure Association 
    Atherosclerosis Society (chairman and member of the executive board)
    Pharmacogenomic and Individualized Treatment Society (vice-chairman) 
    New York Academy of Sciences (not active)
    American Society of Hypertension (not active)
     International College of Angiology (not active)
    Turkish Cardiology Society 
    Turkish Medical Society 
    Istanbul Medical Chamber 

  • Expertise & Areas of interest

    • Hypertension
    • Cardiac insufficiency
    • Atherosclerosis
    • Coronary heart disease
    • Lipid disorders and chronic ischemic heart disease
  • Foreign language

    English 

Publications

Foreign publications

Books
1. Büyüköztürk K, Koylan N, Meriç M, Korkut F, Özsaruhan Ö, Nişancı Y, Güven Ö, Deligönül U, Erzengin F, Özkan E: The effect of oral verapamil in the treatment of essential hypertension. In: "Hypertension- The next decade: Verapamil in Focus", Eds.: A. Fleckenstein and JH Laragh, Churchill- Livingstone, p: 199- 204, 1987.
2. Buğra Z, Meriç M, Koylan N, Adalet K, Nişancı Y, Büyüköztürk K, Ertem G: Long- term effects of coronary angioplasty on signal averaged electrocardiogram. In: “Volumetto Estratto da ICPEP 93”, Editor: A. Oto, Monduzzi Editore S.p.A, Bologna, Italy, p. 15- 18, 1993.
3. Meriç M, Koylan N, Büyüköztürk K: Balloon Mitral Valvuloplasty. In: “Textbook of Angiology”, Ed. Chang JB, Springer- Verlag, New York, Berlin, Heidelberg, 2000. pp: 370- 380.
4. Özben B, Bilge, AK, Koylan N: Cardiovascular aging and cardiovascular diseases in the elderly. In “Frontiers in Neurodegenerative Disorders and Aging: Fundamental aspects, Clinical Perspectives and New Insights”. Eds. T. Özben and M Chevion. IOS Press, 2004, pp: 128- 149.

Articles 
1. Ekmekçi A, Güven Ö, Meriç M, Koylan N: The effect of aspirin on steady state serum digoxin concentrations in man (preliminary report). Turkish J. Res. Med. Sci., 1: 19- 20, 1983.
2. Meriç M, Koylan N, Adalet K, Şamilgil Meriç M, Ekmekçi A, Büyüköztürk K, Ertem G, Özcan R: The clinical use of prazosin in the treatment of congestive heart failure. Med. Bull. Istanbul, 19: 19- 28, 1986.
3. Meriç M, Nişancı Y, Adalet K, Koylan N, Korkut F, Yaşa M, Ertem G: The value of programmed electrical stimulation of the heart in the diagnosis of occult preexcitation syndrome. Med. Bull. Istanbul, 20: 17- 26, 1987.
4. Meriç M, Adalet K, Koylan N, Karabulut N, Arseven A, Ertem G: Treatment of essential hypertension. A comparative study of labetalol and propranolol. Clin. Trials J., 25: 181- 194, 1988.
Article in which this article has been cited:
a) Anonymous: Bibliography Of The Current World Literature In Hypertension. J Hypertens 6 (9): H31-H34, 1988
5. Güven Ö, Koylan N, Öztürk N, Meriç M, Ekmekçi A, Güler K: The effect of aspirin on steady state serum digoxin concentrations and digoxin clearence in patients with congestive heart failure. Turk J Med Biol Res 2: 91- 96, 1991.
6. Seyithanoğlu BY, Atılgan D, Koylan N, Umman S, Meriç M, Ertem G: The importance of plasma fibrin destruction products within the first 24 hours of acute myocardial infarction. Med Bull Istanbul 24: 187- 196, 1991.
7. Meriç M, Gören T, Atılgan D, Eren N, Çubukçu A, Koylan N: Metabolic, hematological, and cardiac effects of long- term Isradipine treatment in mild- to- moderate essential hypertension. J Cardiovasc Pharmacol. 1992;19 Suppl 3:S58-60.
Articles in which this article has been cited:
a) Blecker D: Antihypertensive Therapy With Isradipine In Patients With Special Safety Concerns. Angiology 45 (12): 997-1008, 1994.
b) Marcus AO: Antihypertensive Therapy With The Calcium-Channel Blocker Isradipine - An Appropriate Choice For The Diabetic Patient With Hypertension - A Review Curr Ther Res Clin E 54 (6): 763-778 Dec 1993
8. Beşışık F, Koylan N, Umman S, Nişancı Y: Cardiac abnormalities and complications in a patient with Emery- Dreifuss muscular dystrophy. Med Bull Istanbul 26: 92- 98, 1993.
9. Yılmaz E, Adalet K, Yılmaz G, Badur S, Erzengin F, Koylan N, Özsaruhan Ö, Ertem G, Büyüköztürk K: Importance of serum anticardiolipin antibody levels in coronary heart disease. Clin Cardiol 17: 117- 121, 1994.
Articles in which this article has been cited:
a) Gurlek A, Ozdol C, Pamir G, et al. Association between anticardiolipin antibodies and recurrent cardiac events in patients with acute coronary syndrome. INTERNATIONAL HEART JOURNAL 46 (4): 631-638 JUL 2005
b) Brey RL, Chapman J, Levine SR, et al. Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002. LUPUS 12 (7): 508-513 2003
c) Berliner JI, Rybicki AC, Kaplan RC, et al. Elevated levels of Factor XI are associated with cardiovascular disease in women. THROMBOSIS RESEARCH 107 (1-2): 55-60 JUL 15 2002.
d) Reshetnyak TM, Kotelnikova GP, Fomitcheva OA, et al. Cardiological aspects of the antiphospholipid syndrome. Part I. Valvular lesions in the primary and secondary antiphospholipid syndrome and systemic lupus erythematosus. KARDIOLOGIYA 42 (8): 38-43 2002
e) Brey RL, Abbott RD, Curb JD, Et Al. Beta(2)-Glycoprotein 1-Dependent Anticardiolipin Antibodies And Risk Of Ischemic Stroke And Myocardial Infarction - The Honolulu Heart Program. Stroke 32 (8): 1701-1706, 2001.
f) Seijas M, Vazquez CM, Rivera A, Et Al. Prevalence Of Anti-Phospholipid Syndrome Among Patients Aged Less Than 65 Years With Acute Myocardial Infarction. Rev Clin Esp 201 (3): 118-121, 2001
g) Brighton TA, Chesterman CN: The Clinical Significance Of Antiphospholipid Antibodies In Patients Without Autoimmune Disease. Aust Nz J Med 30 (6): 693-703, 2000
h) Petri M. Epidemiology Of The Antiphospholipid Antibody Syndrome. J Autoimmun 15: (2) 145-151 Sep 2000
i) Guler N, Bilge M, Eryonucu B, et al. Relation between left ventricular and/or left atrial thrombus and anticardiolipin antibodies in patients with acute myocardial infarction. AMERICAN JOURNAL OF CARDIOLOGY 85 (11): 1391+ JUN 1 200
j) Limaye V, Beltrame J, Cook R, Et Al. Evaluation Of Antibodies To Beta 2-Glycoprotein 1 In The Causation Of Coronary Atherosclerosis As Part Of The Antiphospholipid Syndrome. Aust Nz J Med 29: (6) 789-793 Dec 1999
k) Zuckerman E, Toubi E, Shiran A, Et Al. Anticardiolipin Antibodies And Acute Myocardial Infarction In Non-Systemic Lupus Erythmatosus Patients: A Controlled Prospective Study. Am J Med 101: (4) 381-386 Oct 1996
l) Triplett Da. Protean Clinical Presentation Of Antiphospholipid-Protein Antibodies (Apa). Thromb Haemostasis 74: (1) 329-337 Jul 1995.
10. Koylan N, Öncül A, Mercanoğlu F, Orak E, Erzengin F, Büyüköztürk K: The acute effects of cilazapril on left ventricular diastolic functions. J Cardiovasc Pharmacol 24 (Suppl. 3): S42- S44, 1994. 
Article in which this article has been cited:
a) Wachtell K, Bella JN, Rokkedal J, Et Al. Change In Diastolic Left Ventricular Filling After One Year Of Antihypertensive Treatment - The Losartan Intervention For Endpoint Reduction In Hypertension (LIFE) Study. Circulation 105 (9): 1071-1076,  2002.
11. Özsaruhan Ö, Öncül A, Nişancı Y, Umman S, Koylan N, Emel O, Büyüköztürk K, Ertem G: Influence of global system of mobile telephones on permanent pacemakers. Reblampa 8: 157- 158, 1995.
12. Adalet K, Nalbantgil İ, Kılıççıoğlu B, Koylan N, Buğra Z, Adalet I, Orak E, Umman F,Erzengin F, Büyüköztürk K: Multicenter double blind patient comparative trial with benazepril versus captopril in the treatment of mild to moderate hypertension. Med Bull İstanbul 28: 1- 9, 1995.
13. Umman B, Meriç M, Umman S, Koylan N, Adalet K, Nişancı Y, Ertem G: The effects of coronary angioplasty on the global and regional left ventricular function in patients with angina pectoris after anterior myocardial infarction. Int J Angiol 6:199-202, 1997.
14. Buğra Z, Koylan N, Vural A, Erzengin F, Umman B, Yilmaz E, Meriç M, Büyüköztürk  K. Left ventricular geometric patterns and QT dispersion in untreated essential hypertension. Am J Hypertens 11(10):1164-70, 1998. 
Articles in which this article has been cited:
a) Tuncer M, Güneş Y, Güntekin U, et al. Association of increased QTc dispersion and right ventricular hypertrophy. MEDICAL SCIENCE MONITOR 2008, 14(2): CR102-CR105.
b) Gür M, Yılmaz R, Demirbağ R, et al. Relationship between the elastic properties of aorta and QT dispersion in newly diagnosed arterial adult hypertensives. ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY 2007, 7(3): 275-280.
c) Girardot D, Jover B, Moles JP, et al. Chronic nitric oxide synthase inhibition prevents new coronary capillary generation. J Cardiovasc Pharmacol 44 (3): 322-328 SEP 2004
d) Balcı B, Yılmaz O, Yeşildağ O: The influence of ambulatory blood pressure profile on left ventricular geometry. Echocardiography-A Journal Of Cardiovascular Ultrasound And Allied Techniques 21 (1): 7-10 JAN 2004
e) Salles GF, Cardoso CRL, Deccache W: Multivariate associates of QT interval parameters in diabetic patients with arterial hypertension: importance of left ventricular mass and geometric patterns. Journal Of Human Hypertension 17 (8): 561-567 AUG 2003.
f) Seara FJG, Juanatey JRG, Sande JLM, et al. Long-term improvement of QT dispersion is unaffected by short-term changes in blood pressure during treatment of systemic hypertension with enalapril. Annals Of Noninvasive Electrocardiology 8 (1): 47-54 JAN 2003
g) Oikarinen L, Nieminen MS, Viitasalo M, et al. Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. J Hypertens 19 (10): 1883-1891, 2001
h) Wolk R, Mazurek T, Lusawa T, et al. Left ventricular hypertrophy increases transepicardial dispersion of repolarisation in hypertensive patients: a differential effect on QTpeak and QTend dispersion. Eur J Clin Invest 31 (7): 563-569, 2001.
i) Kajander OA, Kupari M, Laippala P, et al. Coronary artery disease modifies left ventricular remodelling due to heavy alcohol consumption. Alcohol Clin Exp Res 25 (2): 246-252, 2001.
j) Hennersdorf MG, Strauer BE. Arterial hypertension and cardiac arrhythmias J Hypertens 19 (2): 167-177, 2001.
k) Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 36 (6): 1749-1766, 2000.
15. Onat A, Tokgözoğlu L, Soydan İ, Sansoy V, Koylan N, Mahley RW. Higher Efficacy of 10 mg/day of Simvastatin in Turkish Patients with Hyperlipidemia,  Türk Kardiyol Dern Arş 2000; 28:635-642
16. Onat A, Soydan I, Tokgözoğlu L, Sansoy V, Koylan N, Domaniç N, Ural D for the Riskburden Study Group: Guideline implementation in a multicenter study with an estimated 44% relative cardiovascular event risk reduction. CLINICAL CARDIOLOGY 26(5): 243- 249, 2003. 
Bu makalenin site edildiği makaleler:
a) van Wyk JT, van Wijk MAM, Sturkenboom MCJM, et al. Identification of the four conventional cardiovascular disease risk factors by Dutch general practitioners. CHEST 128 (4): 2521-2527, 2005.
b) Skrtic S, Niklason A, Leoo T, et al. Risk factor identification and assessment in hypertension and diabetes (RIAHD) study. BLOOD PRESSURE 2006, 15(6): 367-374.
17. Oflaz H, Türkmen A, Kocaman O, Erdoğan D, Meriç M, Öncül A, Koylan N, Yılmaz E, Yılmaz C, Selçukbiricik F, Kaşıkcıoğlu E, Sever MS: Is there a relation between duration of cyclosporine usage and right and left ventricular function in renal transplant patients?: Tissue Doppler echocardiography study. Transplantation Proceedings 36 (5): 1380- 1384, 2004.
Article in which this article has been cited:
a) Balal M, Koç M, Paydaş S, et al. Daily blood pressure control is not sufficient to regress cardiac hypertrophy and dysfunction: A bi-ventricular tissue Doppler echocardiographic study. NEPHROLOGY 2007, 12(2):140-146.
18. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, MacInness GT, Michell L, Plat F, Schork A, Smith B, Zanchetti A for the Value Trial Group (Koylan N in Steering Committee list and Investigator list): Outcomes in hypertensive patients at high cardiovascular risk treated with regimes based on valsartan or amlodipine: The Value Randomized Trial. Lancet 363(9426): 2022-2031 2004. 
Articles in which this article has been cited (total 596)
19. Koylan N, Bilge, AK, Adalet K, Mercanoğlu F, Büyüköztürk K: Comparison of the effects of trimetazidine and diltiazem on exercise performance in patients with coronary heart disease. The Turkish Trimetazidine Study (TTS). Acta Cardiologica 59(6):644- 650, 2004.
Articles in which this article has been cited:
a) McCullough PA. Ranolazine: Focusing on angina pectoris. DRUGS OF TODAY 42 (3): 177-183 MAR 2006.
b) Marzilli M, Affinito S. Meeting the challenge of chronic ischaemic heart disease with trimetazidine. CORONARY ARTERY DISEASE 16: S23-S27 Suppl. 1 NOV 2005.
20. Bilge AK, Atılgan D, Tükek T, Özcan M, Özben B, Koylan N, Meriç M. Effects of amlodipine and fosinopril on heart rate variability and left ventricular mass in mild-to-moderate essential hypertension. Int J Clin Pract, March 2005, 59, 3, 306–310
a) Miziara AN, Molina RJ, Ferreira BDC, et al. Cardiac autonomic modulation in hypertensive patients with Chagas' disease. ACTA TROPICA 2006, 97(2): 188-195.
b) Frishman WH. Calcium channel blockers: Differences between subclasses. AMERİÇAN JOURNAL OF CARDIOVASCULAR DRUGS 2007, 7(Suppl.1): 17-23.
c) Weir MR. Calcium channel blockers: Their pharmacologic and therapeutic role in hypertension. AMERİÇAN JOURNAL OF CARDIOVASCULAR DRUGS 2007, 7(Suppl.1): 5- 15.
d) Michaels AD, Bart BA, Pinto T, et al. The effects of enhanced external counterpulsation on time- and frequency-domain measures of heart rate variability. JOURNAL OF ELECTROCARDIOLOGY 2007, 40(6): 515-521. 
21. Pamukçu B, Oflaz H, Acar RD, Umman S, Koylan N, Umman B, Nişancı Y. The role of exercise on platelet aggregation in patients with stable coronary artery disease: exercise induces aspirin resistant platelet activation. J Thromb Thrombolysis. 2005 Aug;20(1):17-22. 
Articles in which this article has been cited:
a) Pamukçu B, Oflaz H, Öncüll A, et al. The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events. JOURNAL OF THROMBOSIS AND THROMBOLYSIS 2006, 22(2): 103-110.
b) Lordkipanidze M, Pharand C, Palisaitis DA, et al. Aspirin resistance: Truth or dare. PHARMACOLOGY & THERAPEUTICS 2006, 112(3): 733-743.
c) Falluji N, Steinhubl SR. Variable response to antiplatelet therapy: What does it mean to clinicians? Source: CLEVELAND CLINIC JOURNAL OF MEDICINE 2007, 74(1): 49-55.
d) Hovens MMC, Snoep JD, Eikenboom JCJ, et al. Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review. AMERICAN HEART JOURNAL 2007, 153(2): 175-181.
e) Kahraman G, Şahin T, Kılıç T, et al. The frequency of aspirin resistance and its risk factors in patients with metabolic syndrome. INTERNATIONAL JOURNAL OF CARDIOLOGY 2007, 115(3): 391-396.
f) Pamukçu B, Oflaz H, Onur I, et al. Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PROSPECTAR). BLOOD COAGULATION & FIBRINOLYSIS 2007, 18(2): 187-192.
g) Pamukçu B. A review of aspirin resistance; definition, possible mechanisms, detection with platelet function tests, and its clinical outcomes. JOURNAL OF THROMBOSIS AND THROMBOLYSIS 2007, 23(3): 213-222.
h) Poulsen TS, Jorgensen B, Korsholm L, et al. Prevalence of aspirin resistance in patients with an evolving acute myocardial infarction. THROMBOSIS RESEARCH 2007, 119(5): 555-562.
i) Pamukçu B, Oflaz H, Onur M, et al. Aspirin-resistant platelet aggregation in a cohort of patients with coronary heart disease. BLOOD COAGULATION & FIBRINOLYSIS 2007, 18(5): 461-465.
j) Pamukçu B, Oflaz H, Onur L, et al. Relationship between the serum sCD40L level and aspirin-resistant platelet aggregation in patients with stable coronary artery disease 
CIRCULATION 2008, 72(1): 61-66. 
k) Crescente M, Di Castelnuovo A, Lacoviello L, et al. Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100 - A systematic review. THROMBOSIS AND HAEMOSTASIS 2008, 99(1): 14-26. 
l) Tseeng S, Arora R. Aspirin resistance: Biological and clinical implications 
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS 2008, 13(1): 5-12.
m) Pamukçu B, Oflaz H, Nişancı Y. A current problem in atherothrombotic diseases aspirin resistance: Definition, mechanisms, determination with laboratory tests and clinical implications. ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY 2007, 7(suppl.2): 20-26. 
22. Koylan N, Acartürk E, Canberk A, Çağlar N, Çağlar S, Erdine S, Güneri S, İlerigelen B, Kabakçı G, Önder R, Sağkan O, Büyüköztürk K. Effect of irbesartan monotherapy compared with ACE inhibitors and calcium-channel blockers on patient compliance in essential hypertension patients: A multicenter, open-labeled, three-armed study. Blood Press. 2005 Jul 1;14 Suppl 1:23-31.
Articles in which this article has been cited:
a) Hedner T, Narkiewicz K, Kjeldsen SE. Hypertension control - A global challenge. Source: BLOOD PRESSURE 2005, 14(Suppl.1): 4-5.
23. Oflaz H, Cuhadaroğlu C, Pamukçu B, Meriç M, Ece T, Kaşıkçıoğlu E, Koylan N. Endothelial Function in Patients with Obstructive Sleep Apnea Syndrome but without Hypertension. Respiration 2006, 73(6): 751- 756.
Articles in which this article has been cited:
a) Aittokallio J, Polo O, Hiissa J, et al. Overnight variability in transcutaneous carbon dioxide predicts vascular impairment in women. EXPERIMENTAL PHYSIOLOGY 2008, 93(7): 880- 891.
b) Cherniack NS. N-terminal pro-B-type naturetic peptide (NTBNP): so much promise and such a disappointment. SLEEP AND BREATHING 2008, 12(1): 3-5.
c) Fritscher LG, Canani S, Mottin CC, et al. Bariatric surgery in the treatment of obstructive sleep apnea in morbidly obese patients. RESPIRATION  2007, 74(6): 647- 652.
d) Ursavas A, Karadag M, Rodoplu E, et al. Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome. RESPIRATION 2007, 74(5): 525- 532.
e) Ainslie PN, Barach A, Cummings KJ, et al. Cardiorespiratory and cerebrovascular responses to acute poikilocapnic hypoxia following intermittent and continuous exposure to hypoxia in humans. JOURNAL OF APPLIED PHYSIOLOGY 2007, 102)5): 1953- 1961.
f) Cherniack NS. What's a good night's sleep worth? RESPIRATION 73(6): 735-736.
24. Julius S, Weber MA, Kjeldsen SE, McInnes GT, Zanchetti A, Brunner HR, Laragh J, Schork MA, Hua TA, Amerena J, Balazovjech I, Cassel G, Herczeg B, Koylan N, Magometschnigg D, Majahalme S, Martinez F, Oigman W, Seabra Gomes R, Zhu JR.  The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy. Hypertension. 2006 48(3):385-91.
Articles in which this article has been cited:
a) Anonymous. Valsartan appears more effective than amlodipine in prevent HF, diabetes in patients with hypertension. Formulary 2006, 41(10): 527.
b) Sica DA. The valsartan antihypertensive long-term use evaluation trial - A study in contrasts. HYPERTENSION 2006, 48(3): 362-363.
c) Kaplan NM. Clinical trials for hypertension - Expectations fulfilled and unfulfilled. HYPERTENSION 2007, 49(2): 257-259.
d) Sigurdsson ST, Strandgaard S: Blood pressure lowering in acute ischaemic stroke: an update on the role of angiotensin receptor blockers. JOURNAL OF HYPERTENSION 2007, 25(4): 743-745.
e) Dusing R: New-onset diabetes mellitus during antihypertensive treatment. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 2007, 132(13): 689-695.
f) Chrysant SG, Sugimoto DH, Lefkowitz M, et al.: The effects of high-dose amlodipine/benazepril combination therapies on blood pressure reduction in patients not adequately controlled with amlodipine monotherapy. BLOOD PRESSURE 2007, 16 (Suppl.1): 10-17. 
g) Oparil S, Yarows SA, Patel S, et al. Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial. LANCET 2007, 370(9583): 221-229.
h) Epstein BJ, Vogelz K, Palmer BF. Dihydropyridine calcium channel antagonists in the management of hypertension. DRUGS 2007, 67(9): 1309-1327.
i) Wang JG, Li Y. Response to can large-scale trials or meta-analyses demonstrate blood pressure-independent effect of angiotensin receptor blockers? HYPERTENSION 2007, 50(4): E74-E74.
j) Aulakh GK, Sodhi RK, Singh M. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators. LIFE SCIENCES 2007, 81(8): 615-639.
k) Yamamoto E, Kataoka K, Shintaku H, et al. Novel mechanism and role of angiotensin II-Induced vascular endothelial injury in hypertensive diastolic heart failure. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 2007, 27(12): 2569-2575. 
l) Kjeldsen SE, Oparil S, Narkiewicz K, et al. Ambulatory blood pressure adds to explaining benefits of AT-1 receptor blockade in the treatment of left ventricular hypertrophy. BLOOD PRESSURE 2007, 16(6): 344-346. 
m) Weber MA. Secondary analysis of the VALUE trial: Intriguing new questions. CURRENT HYPERTENSION REPORTS 2007, 9(4): 261-263. 
n) Choy CK, Rodgers JE, Nappi JM, et al. Type 2 diabetes mellitus and heart failure. PHARMACOTHERAPY 2008, 28(2): 170-192.
o) Shafiq MM, Menon DV, Victor RG. Oral direct renin inhibition: Premise, promise, and potential limitations of a new antihypertensive drug. AMERİÇAN JOURNAL OF MEDICINE 2008, 121(4): 265-271. 
p) Papadopoulosa DP, Papademetriou V. Aggressive blood pressure control and stroke prevention: role of calcium channel blockers. JOURNAL OF HYPERTENSION 2008, 26(5): 844-852. 
q) Williams B. The year in hypertension. JOURNAL OF THE AMERİÇAN COLLEGE OF CARDIOLOGY 2008, 51(18): 1803-1817. 
25. Büyüköztürk  K, İlerigelen B, Kabakçı G, Koylan N, Kozan O. Intensive Cardiovascular Examination regarding Blood pressure levels: Evaluation of Risk Groups. ICEBERG study. BLOOD PRESSURE 2006, 15(5): 291-301.  
26. Pamukçu B, Oflaz H, Onur M, Öncül A, Umman B, Koylan N, Buğra Z, Meriç M, Nişancı Y. Aspirin-resistant platelet aggregation in a cohort of patients with coronary heart disease. BLOOD COAGULATION & FIBRINOLYSIS 2007, 18(5): 461-465. 
Articles in which this article has been cited:
a) Ghosh K, Shetty S, Mota L. Aspirin resistance in patients with coronary artery disease - which test to use in routine management? BLOOD COAGULATION & FIBRINOLYSIS 2008, 19(4): 324-326.
b) Crescente M, Di Castelnuovo A, Lacoviello L, et al. Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100 - A systematic review. THROMBOSIS AND HAEMOSTASIS 2008, 99(1): 14- 26.
27. Deedwania P, Stone PH, Merz CNB, Cosin-Aguilar J, Koylan N, Luo D, Ouyang P, Piotrowicz R, Schenck-Gustafsson K, Sellier P, Stein JH, Thompson PL, Tzivoni D. Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease - Results of the Study Assessing Goals in the Elderly (SAGE). CIRCULATION 2007, 115(6):700-707.
Articles in which this article has been cited:
a) Gotto AM:  Statin therapy and the elderly SAGE advice?  CIRCULATION  2007, 115(6): 681-683.
b) Wenger NK, Lewis SJ, Herrington DM, et al. Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease. ANNALS OF INTERNAL MEDICINE  2007, 147(1): 1-9.
c) Davidson MH: Rosuvastatin in elderly patients . DRUGS & AGING 2007, 24(11):933-944.
d) Arca M. Atorvastatin - A safety and tolerability profile. DRUGS 2007, 67(Suppl.1): 63-69.
e) Duivenvoorden R, Nederveen AJ, De Groot E, et al. Atherosclerosis imaging as a benchmark in the development of novel cardiovasular drugs. CURRENT OPINION IN LIPIDOLOGY 2007, 18(6):613-621.
f) Josan K, Majumdar SR, McAlister FA. The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials. CANADIAN MEDICAL ASSOCIATION JOURNAL 2008, 178(5): 576-584
g) Jolicoeur EM, Granger CB, Henry TD, et al. Clinical and research issues regarding chronic advanced coronary artery disease: Part I: Contemporary and emerging therapies. AMERICAN HEART JOURNAL 2008, 155(3): 418-434.
h) Shepherd J. Monotherapy vs combination therapy for dyslipidemia in the elderly. AMERİÇAN JOURNAL OF GERIATRIC CARDIOLOGY 2008, 17(2):108-113.
i) Maroo BP, Lavie CJ, Milani RV. Efficacy and Safety of intensive statin therapy in the elderly. AMERICAN JOURNAL OF GERIATRIC CARDIOLOGY 2008, 17(2):92-100.
j) Robinson JG. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk. AMERICAN JOURNAL OF CARDIOLOGY 2008, 101(7): 1009-1015.
k) Bybee KA, Lee JH, O'Keefe JH: Cumulative clinical trial data on atorvastatin for reducing cardiovascular events: the clinical impact of atorvastatin. CURRENT MEDICAL RESEARCH AND OPINION 2008, 24(4): 1217-1229.
28. Kabakçı G, Koylan N, İlerigelen B, Kozan Ö, Büyüköztürk K. The impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: Results from the ICEBERG study. Türk Kardiyol Dern Arş. (Arch Turk Soc Cardiol) 2007;35(8):458-466
29. Kabakçı G, Koylan N, Kozan O, Büyüköztürk  K, İlerigelen B; ICEBERG Investigators. Evaluation of the metabolic syndrome in hypertensive patients: results from the ICEBERG Study. J Cardiometab Syndr. 2007 Summer;2(3):168-73.
30. Kozan O, Büyüköztürk  K, İlerigelen B, Kabakçı G, Koylan N; ICEBERG Investigators. The impact of plasma high-sensitivity C-reactive protein levels on cardiovascular risk stratification of hypertensive patients: results of the ICEBERG study. J Clin Hypertens (Greenwich). 2007 Jul;9(7):500-5.
31. Julius S, Palatini P, Kjeldsen SE, Zanchetti A, Weber MA, McInnes GT, Brunner HR, Mancia G, Schork MA, Hua TA, Holzhauer B, Zappe D, Majahalme S, Jamerson K, and Koylan N. Usefulness of Heart Rate to Predict Cardiac Events in Treated Patients with High Risk Systemic Hypertension. Amer J Cardiol (accepted and scheduled for publication in March 2012).
Papers
1. Ekmekçi A, Güven Ö, Meriç M, Sandalcı Ö, Koylan N, Özcan R, Deligönül U, Büyüköztürk K, Işık K, Berkmen R, Ertem G: The effect of aspirin on steady state serum digoxin levels in cardiac patients. Third Joint Meeting of the Working Groups of European Society of Cardiology, 5- 7 September 1983, SPA, Belgium. European Heart J, 4 (Suppl. E): 42, 1983.
THIS PAPER IS COVERED BY SCI.
2. Koylan N, Ekmekçi A, Erdemgüler T, Çalangu S, Oral T, Meriç M, Canberk A: The acute antihypertensive effectiveness of sublingual nifedipine compared with intravenous furosemide in hypertensive emergencies. Cardiovascular Pharmacotherapy International Symposium, 22- 25 April 1985, Geneva, Switzerland. Abst. Book No: 14.
3. Büyüköztürk K, Koylan N, Meriç M, Korkut F, Özsaruhan Ö, Nişancı Y, Güven Ö, Deligönül U, Erzengin F, Özkan E: The effect of oral verapamil in the treatment of essential hypertension. 
a) Second European Meeting on Hypertension, 9- 12 June 1985, Milan, Italy. Abst. Book (Ricerca Scientifica ed Educazione Permanente); suppl. no: 49, Abst. no: 68, 1985. 
b) International Symposium on Calcium and Calcium Antagonists in Hypertension - Satellite Symposium to the Second European Meeting on Hypertension, 9 June 1985, Milan, Italy. 
c) Hypertension- The next decade: Verapamil in focus. 10- 11 October, 1986, Berlin ICC, West Germany.
4. Büyüköztürk K, Levi S, Meriç M, Koylan N, Erzengin F, Özsaruhan Ö, Özkan E, Özcan R: The effects of intravenous verapamil in essential hypertension. Xth World Congress of Cardiology, 14- 19 September 1986, Washington DC, USA. Abst. Book, No: 1112.
5. Ekmekçi A, Boztaş G, Meriç M, Koylan N, Adalet K, Canberk A, Ertem G, Özcan R: Investigation of the erythrocyte fluid volume in normotensive children of patients with essential hypertension. Xth World Congress of Cardiology, 14- 19 September 1986, Washington DC, USA. Abst. Book, No: 2081.
6. Ekmekçi A, Seyithanoğlu Y, Meriç M, Koylan N, Adalet K, Ertem G, Özcan R: The importance of serum F/FDP level in determination of short term prognosis after myocardial infarction. Xth World Congress of Cardiology, 14- 19 September 1986, Washington DC, USA. Abst. Book, No: 2082.
7. Ekmekçi A, Kazancıoğlu R, Meriç M, Adalet K, Koylan N, Ertem G, Özcan R: The effects of beta- blocker agents with or without intrinsic sympathomimetic activity on plasma lipid fractions. The Mediteranean Meeting on Cardiology, 7- 9 October 1986, Nice, France.
8. Meriç M, Gören T, Atılgan D, Eren N, Çubukçu A, Koylan N: The metabolic, hematologic and cardiologic effects of the long term isradipine treatment patients with mild and moderate in hypertension. Fifth European Meeting on Hypertension, 7- 10 June 1991, Milan, Italy. Ricerca Scientifica ed Educazione Permanente, Supplemento n. 90- 1991, Abst. no: 454.
9. Yılmaz E, Adalet K, Yılmaz G, Badur S, Erzengin F, Koylan N, Özsaruhan Ö, Çetin ET, Büyüköztürk K: Importance of serum anticardiolipin antibody levels in coronary heart disease (a preliminary study). XIIIth Congress of the European Society of Cardiology, 18- 22 August 1991, Amsterdam, The Netherlands. Eur Heart J 12: Abstract Supplement, August 1991, Abst no: P1082.
10. Nalbantgil İ, Adalet K, Orak E, Buğra Z, Umman B, Adalet I, Koylan N, Erzengin F, Büyüköztürk K: Multicenter, double- blind between patient comparative trial with benazepril and captopril in the treatment of mild to moderate hypertension. 5th International Symposium on Cardiovascular Pharmacotherapy, 10- 12 July 1993, Minneapolis, Minnesota, USA. Cardiovasc Drugs Ther 7 (Suppl 2): 419, 1993, Abst.no:119.
11. Buğra Z, Meriç M, Koylan N, Adalet K, Nişancı Y, Büyüköztürk K, Ertem G: Long- term effects of coronary angioplasty on signal averaged electrocardiogram. 4th International Congress on Cardiac Pacing and Electrophysiology, 3- 6 October 1993, Antalya, Turkey. Eur J Cardiac Pacing Electrophysiol 3 (Number 3)(Suppl.2A): A30, 1993, Abst.no: 87.
12. Umman B, Meriç M, Umman S, Koylan N, Adalet K, Nişancı Y, Ertem G: The effects of coronary angioplasty on the global and regional left ventricular function after anterior myocardial infarction in patients with angina pectoris. XVth Congress of the European Society of Cardiology, 29 August- 2 September 1993, Nice, France. Eur Heart J 14 (Abstract Supplement): 471, 1993. Abstract no: P2601.
13. Koylan N, Öncül A, Mercanoğlu F, Orak E, Erzengin F, Büyüköztürk K: The acute effects of cilazapril on left ventricular diastolic functions. A vascular protective concept in hypertension and heart failure- 4th International Symposium on Cilazapril, 26 November 1993, İstanbul, Turkey. Abstracts Book, p.25.
14. Koylan N, Altuğ T, Güzel Ö, Mercanoğlu F, Öncül A, Gündoğdu R: Lipoprotein(a) levels and its relation with other lipids in documented coronary artery disease patients and in healthy subjects. 4th Turkish- Polish Cardiology Days, 6- 7 June 1994, İstanbul, Turkey.Türk Kardiyol Dern Arş 22: 213, 1994.
15. Öncül A, Özsaruhan Ö, Umman S, Nişancı Y, Erzengin F, Koylan N, Meriç M, Büyüköztürk K, Ertem G: Comparison of 'Sensor blended and cross checked' rate of double sensored, doube chamber pacemakers with normals. Cardiostim 94- 9th International Congress, 12- 14 June 1994, Nice, France. Eur J Cardiac Pacing Electrophysiol 4(Suppl.4): 54, 1994. Abstract no: 227.
16. Koylan N, Altuğ T, Güzel Ö, Öncül A, Mercanoğlu F, Gündoğdu R, Ertem G: Interaction of lipid fractions and lipoprotein(a) in coronary heart disease. 36th Annual World Congress of International College of Angiology, 2- 9 July, 1994, New York City, New York, USA. Abstracts Book, p.72- 73.
17. Canberk A, Koylan N, Gülbaba G, Mercanoğlu F: The effect of nitrendipine on plasma endothelin-I levels. 36th Annual World Congress of International College of Angiology, 2- 9 July, 1994, New York City, New York, USA. Abstracts Book, p.73- 74.
18. Çefle K, Koylan N, Okur Ö, Adalet K, Orak E, Helvacı A, Mercanoğlu F, Meriç M, Ertem G, Büyüköztürk K: The effect of propafenone on signal averaged electrocardiogram. 36th Annual World Congress of International College of Angiology, 2- 9 July, 1994, New York City, New York, USA. Abstracts Book, p.76- 77.
19. Koylan N, Atılgan D, Canberk A, Buğra Z, Büyüköztürk K: Signal averaged electrocardiographic findings in mild to moderate essential hypertension. Joint XIIth World Congress of Cardiology and XVIth Congress of European Society of Cardiology, September 10- 14, 1994, Berlin, Germany. Eur Heart J 15: (Abstract Supplement, August 1994. Abstract no: P1557.
20. Öncül A, Özsaruhan Ö, Nişancı Y, Umman S, Buğra Z, Adalet K, Koylan N, Büyüköztürk K, Ertem G: Incidence of chronic atrial fibrillation in single or double chamber permanent pacing with or without rate response. Europace 95- 7th European Symposium on Cardiac Pacing, June 4- 7, 1995, İstanbul, Turkey. Pacing and Clinical Electrophysiology, 18(5): 1210, abst.no: 426.
21. Koylan N, Buğra Z, Vural A, Sezer A, Büyüköztürk K: The acute effects of nisoldipine on left ventricular diastolic function and QT dispersion in patients with mild to moderate essential hypertension. 2nd European Meeting on Calcium Antagonists, Amsterdam, The Netherlands, October 25- 27, 1995. Abstract Book, p.36.
22. Koylan N, Adalet K, Erzengin F, Büyüköztürk K, Cordan J, Oram E, Özbay G, Sağkan O, Timuralp B: The effects of slow release verapamil on exercise performance in patients with coronary heart disease. 2nd European Meeting on Calcium Antagonists, Amsterdam, The Netherlands, October 25- 27, 1995. Abstract Book, p.47.
23. Koylan N: New perspectives in the control of renin- angiotensin system: Angiotensin II antagonism and the expectations. Turkish German Joint Meeting on Hypertension and Atherosclerosis, 21- 25 April 1996, Marmaris, Turkey. Abstract Book p.49.
24. Canberk A, Delier H, Batum B, Üresin Y, Koylan N, Öncül A: Evaluation of glucose tolerance and insulin resistance syndrome in patients with mild to moderate essential hypertension. Turkish German Joint Meeting on Hypertension and Atherosclerosis, 21- 25 April 1996, Marmaris, Turkey. Abstract Book p.83.
25. Koylan N, Umman B, Azarbaz M, Erzengin F, Büyüköztürk K: The effects of various calcium antagonists on the late potentials and QT dispersion. Turkish German Joint Meeting on Hypertension and Atherosclerosis, 21- 25 April 1996, Marmaris, Turkey. Abstract Book p.95.
26. Buğra Z, Koylan N, Vural A, Umman B, Mercanoğlu F, Sağbaş A, Erzengin F, Meriç M, Büyüköztürk K: Left ventricular hypertrophy patterns and ventricular remodeling in patients with essential hypertension. Turkish German Joint Meeting on Hypertension and Atherosclerosis, 21- 25 April 1996, Marmaris, Turkey. Abstract Book p.130.
27. Buğra Z, Koylan N, Vural A, Erzengin F, Umman B, Yılmaz E, Meriç M, Büyüköztürk K: Left ventricular hypertrophy patterns, ventricular remodeling and QT dispersion in untreated essential hypertension. A) The AMeriçan Society of Hypertension 20th. Scientific Meeting, San Francisco, USA, May 27- 30, 1997. Amer J Hypertens Abstract Issue10 (4): 53A, 1997. B) XIXth Congress of the European Society of Cardiology, Stockholm, Sweden, 24- 28 August 1997, Eur Heart J 18:116 (741), 1997.
28. Buğra Z, Mercanoğlu F, Vural A, Koylan N, Erzengin F, Büyüköztürk K: Short- term effects of the long- acting angiotensin converting enzyme inhibitor trandolapril on left ventricular diastolic filling indexes in hypertensive patients. The AMeriçan Society of Hypertension 20th. Scientific Meeting, San Francisco, USA, May 27- 30, 1997. Amer J Hypertens Abstract Issue10 (4): D111, 1997.
29. Atılgan D, Koylan N, Akkaya V, Meriç M, Büyüköztürk K. Does mitral stenosis without atrial fibrillation have detrimental effects on left atrial appendage functions? A transesophageal echocardiographic study. XIIIth World Congress of Cardiology, April26- 30, 1998, Rio de Janeiro, Brazil. J Amer Coll Cardiol 31:188C, 1998.
30. Koylan N, Taşköprü İ, Karşıdağ K, Oflaz H, Büyüköztürk K: The use of heart rate variability in the diagnosis of diabetic autonomic neuropathy in patients with non insulin dependent diabetes mellitus. XIIIth World Congress of Cardiology, April26- 30, 1998, Rio de Janeiro, Brazil. J Amer Coll Cardiol 31:188C, 1998.
31. Koylan N, Taşköprü İ, Karşıdağ K, Oflaz H, Büyüköztürk K: QT dispersion as a new method for the diagnosis of diabetic autonomic neuropathy in patients with non insulin dependent diabetes mellitus. XIIIth World Congress of Cardiology, April26- 30, 1998, Rio de Janeiro, Brazil. J Amer Coll Cardiol 31:189C, 1998.
32. Koylan N, Pakhoo M, İspir T, Atılgan D, Meriç M, Büyüköztürk K: The comparison of the effects of perindopril and losartan on red cell membrane ATPase levels in patients with mild to moderate essential hypertension. . XIIIth World Congress of Cardiology, April26- 30, 1998, Rio de Janeiro, Brazil. J Amer Coll Cardiol 31:189C, 1998.
33. Koylan N, Pakhoo M, İspir T, Atılgan D, Meriç M, Büyüköztürk K: The comparison of the effects of perindopril and losartan on plasma malondialdehyde levels in patients with mild to moderate essential hypertension. . XIIIth World Congress of Cardiology, April26- 30, 1998, Rio de Janeiro, Brazil. J Amer Coll Cardiol 31:189C, 1998.
34. Küçükbasmacı Ö, Anğ Ö, Bozkaya E, Küçükbasmacı F, Koylan N: Association of helicobacter pylori infection with coronary heart disease and cardiovascular risk factors. 8th. International Congress of Infectious Diseases, Boston, MA, USA, May 15- 18, 1998.
35. Koylan N, Topbaş A, Erzengin F: The effects of losartan on prolactin, TSH and cortisol plasma levels. 46th World Annual Assembly of the AMeriçan College of Angiology,Kamuela, Hawaii, USA, October 3- 8 1999.
36. Tokgözoğlu L, Koylan N, Soydan I, Domaniç N, Enar R, Atalar E, Kayıkçıoğlu M. Effects of low dose pravastatin theraphy on endothelium generated mediators and thrombotic tendency in patients with hypercholesterolaemia. XXIIth Congress of the European Society of Cardiology, Eur Heart J 21: P974 Suppl. S, 2000.
Articles in which this paper has been cited:
a) Bang LM, Goa KL. Pravastatin - A review of its use in elderly patients. DRUGS & AGING 20 (14): 1061-1082 2003
b) Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA-J Am Med Assoc 285 (4): 430-436, 2001
37. Koylan N, Sever MŞ, İlerigelen B, Önder R, Çağlar Ş: The gap between the clinical measurements and ambulatory blood pressure means in the Treatment and Ambulatory Blood Pressures (TRAP) study. 4th International Symposium on Angiotensin II Antagonism, 3- 5 April 2001, London, UK. Abstract Book PC 46.
38. Koylan N, Sever MŞ, İlerigelen B, Önder R, Çağlar Ş: The frequency and duration of white coat effect and the reliability of 27- hour ambulatory blood pressure monitoring in the Treatment and Ambulatory Blood Pressures (TRAP) study. 4th International Symposium on Angiotensin II Antagonism, 3- 5 April 2001, London, UK. Abstract Book PC 47.
39. Koylan N, Sever MŞ, İlerigelen B, Önder R, Çağlar Ş: Morning surge of blood pressure in the elderly is more prominent than younger patients in the Treatment and Ambulatory Blood Pressures (TRAP) study. 4th International Symposium on Angiotensin II Antagonism, 3- 5 April 2001, London, UK. Abstract Book PC 54.
40. Koylan N, Sever MŞ, İlerigelen B, Önder R, Çağlar Ş: The gap between the clinical measurements and ambulatory blood pressure means in the Treatment and Ambulatory Blood Pressures (TRAP) study. AMeriçan Society of Hypertension 16th Annual Scientific Meeting and Exposition, 15- 19 May, 2001, San Francisco, CA, USA. AMeriçan Journal of Hypertension 14(4): 52A, 2001 
41. Koylan N, Sever MŞ, İlerigelen B, Önder R, Çağlar Ş: The frequency and duration of white coat effect and the reliability of 27- hour ambulatory blood pressure monitoring in the Treatment and Ambulatory Blood Pressures (TRAP) study. AMeriçan Society of Hypertension 16th Annual Scientific Meeting and Exposition, 15- 19 May, 2001, San Francisco, CA, USA. AMeriçan Journal of Hypertension 14(4): 52A, 2001.
42. Koylan N, Sever MŞ, İlerigelen B, Önder R, Çağlar Ş: Morning surge of blood pressure in the elderly is more prominent than younger patients in the Treatment and Ambulatory Blood Pressures (TRAP) study. AMeriçan Society of Hypertension 16th Annual Scientific Meeting and Exposition, 15- 19 May, 2001, San Francisco, CA, USA. AMeriçan Journal of Hypertension 14(4): 52A, 2001.
43. Atılgan D, Koylan N, Tükek T, Bilge AK, Özcan M, Korkut F, Meriç M: Effects of amlodipine and fosinopril on heart rate variability and left ventricular mass in essential hypertension. AMeriçan Society of Hypertension 17th Annual Scientific Meeting, 14- 18 May, 2002, New York Marriott Marquis, New York, NY, USA. AMeriçan Journal of Hypertension 15(4):  35A, 2002.
44. Tokgözoğlu L, Salomon H, Bernard M- D, Koylan N, Görpe U, Akgün G, Akalın S, Yüksel H, Domaniç N, Arslan M, Satman İ, Erdoğan G: An open- label clinical trial evaluating the efficacy and safety of co- micronized fenofibrate (200 mg capsules) once a day in Turkish dyslipidemic patients over 12 weeks of treatment. 6th International Symposium on Global Risk on Coronary Heart Disease and Stroke: Assassment, Prevention and treatment. Florence, Italy, June 12- 15, 2002.
45. Koylan N, Acartürk E, Çağlar N, Çağlar S, Erdine S, Güneri S, İlerigelen B, Kabakçı G, Önder R, Sağkan O: Effect of irbesartan monotherapy compared with ACE inhibitors and calcium channel blockers on patient compliance in patients with essential hypertension: A multicenter, randomized, open- cohort study. Thirteenth European Meeting Of Hypertension, June 13- 17, 2003, Milan, Italy,. J Hypertens 21(Suppl.4) : S73, P1.191, 2003. 
THIS PAPER IS COVERED BY SCI.
46. Oflaz H, Çuhadaroğlu Ç, Pamukçu B, Bilge AK, Ece T, Koylan N: Endothelial function in patients with sleep APNEA but without hypertension. AMeriçan Society of Hypertension 19th Annual Scientific Meeting, 18- 22 May, 2004, New York Marriott Marquis, New York, NY, USA. American Journal of Hypertension 17(5):  71A- P108, 2004. 
THIS PAPER IS COVERED BY SCI.
47. Pamukçu B, Oflaz H, Acar RD, Umman S, Koylan N, Umman B, Nişancı Y. The role of exercise on platelet aggregation in patients with stable coronary artery disease: exercise induces aspirin resistant platelet activation. EUROPEAN HEART JOURNAL 2005, 26(Suppl.1): 255. 
BU BİLDİRİ SCI KAPSAMINDADIR.
48. İlerigelen, B, Kabakçı, G, Koylan N, Kozan Ö, Büyüköztürk K. Coexisting dyslipidemia in hypertensive patients. ATHEROSCLEROSIS SUPP 6 (1): 156-156 APR 2005
THIS PAPER IS COVERED BY SCI.
49. Büyüköztürk , K, İlerigelen, B, Kabakçı, G, Koylan N, Kozan Ö. The impact of hs-CRP on risk evaluation in hypertensive patients: Lessons learned from ICEBERG study. ATHEROSCLEROSIS SUPP 2005, 6 (1): 153-154.
THIS PAPER IS COVERED BY SCI.
50. Kozan O, Koylan N, Büyüköztürk  K, İlerigelen B, Kabakçı G, Kanbolat M, Toker S.  The impact of microalbuminuria and hs-CRP on risk evaluation in people with high-normal and high blood pressure: Results from ICEBERG studyAm J Hypertens 2005, 18(5 Part 2 Suppl. S):: 1A-1A 
THIS PAPER IS COVERED BY SCI.
51. Büyüköztürk  K, İlerigelen B, Kabakçı G, Kozan O, Koylan N, Kanbolat M, Toker S. The impact of multiple laboratory testing on risk evaluation in people with high-normal and high blood pressure: Results from iceberg study. AMERICAN JOURNAL OF HYPERTENSION 2005, 18(5 Part 2 Suppl. S): 141A-141A. 
THIS PAPER IS COVERED BY SCI.
52. İlerigelen B, Kabakçı G, Kozan O, Koylan N, Büyüköztürk  K, Kanbolat M, Toker S. The impact of echocardiography and carotid ultrasonography on risk evaluation in people with high-normal and high blood pressure: Results from iceberg study. AMERICAN JOURNAL OF HYPERTENSION  2005, 18(5 Part 2 Suppl. S): 145A-145A. 
THIS PAPER IS COVERED BY SCI.
53. Koylan N, Büyüköztürk  K, İlerigelen B, Kabakçı G, Kozan O, Kanbolat M, Toker S. The impact of echocardiography on the detection of left ventricular hypertrophy in people with high-normal and high blood pressure: Results from iceberg study. AMERICAN JOURNAL OF HYPERTENSION  2005, 18(5 Part 2 Suppl. S): 145A-146A.
THIS PAPER IS COVERED BY SCI.
54. Kabakçı G, Koylan N, Büyüköztürk  K, İlerigelen B, Kozan O, Kanbolat M, Toker S. The impact of microalbuminuria measured by qualitative or quantitative methods on risk evaluation in hypertensive patients: Results from iceberg study. AMERICAN JOURNAL OF HYPERTENSION  2005, 18(5 Part 2 Suppl. S): 146A-146A.
THIS PAPER IS COVERED BY SCI.
55. İlerigelen B, Kabakçı G, Koylan N, Kozan O, Kanbolat M, Toker S, Büyüköztürk  K. The factors correlated with microalbuminuria in hypertensive patients. European Society of Cardiology Congress 3–7 September 2005, Stockholm – Sweden.  EUROPEAN HEART JOURNAL 2005, 26 (Suppl.1): 168. THIS PAPER IS COVERED BY SCI.
56. Kabakçı G, Koylan N, Kozan O, İlerigelen B, Büyüköztürk K. Cardiovascular risk classification in hypertensive patients with or without metabolic syndrome: Results from the ICEBERG study. ACC 2006, Atlanta, Georgia, 11-14 March 2006. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 2006, 47(4- Suppl. A): 311A-312A. THIS PAPER IS COVERED BY SCI.
57. Kabakçı, G; İlerigelen, B; Koylan, N, Kozan O, Büyüköztürk , K. Routine assessment of risk factors in hypertensive patients as recommended by ESC/ESH hypertension guidelines: Do physicians ignore the importance of risk factors? JOURNAL OF HYPERTENSION 2008, 26: S300. THIS PAPER IS COVERED BY SCI.
Publications in Turkish.
Books
1. a) Ekmekçi A, Koylan N: Changes in serum cholinesterase levels. "Digitalis Toxicity", Ed. N. Akpınar, Ege University Medical School Book of the Month, No: 48, Istanbul (page 22- 23).890
b)Koylan N, Ekmekçi A, Canberk A: Digitalis sensitivity.  "Digitalis Toxicity", Ed. N. Akpınar, Ege University Medical School Book of the Month, No: 48, Istanbul (page 35- 39).
2. Ekmekçi A, Meriç M, Canberk A, Koylan N: Digitalis poisoning.  "Diagnosis and Treatment in Emergency Heart Diseases", Ed.: K. Işık, Beta Basım ve Dağıtım A. Ş., Klinik Seri: 5, 1986, p.: 251, 264, Istanbul.
3. a) Ekmekçi A, Koylan N: Hypertensions based on renal and other reasons, and their treatment.  "Hypertension", Ed. A. Gürçay, Vakur Ltd., Ankara, 1987 (p.:103- 112).
b) Ekmekçi A, Koylan N: Use of antihypertensive drugs and general condition.  "Hypertension", Ed. A. Gürçay, Vakur Ltd., Ankara, 1987 (p.: 113- 133).
4. a) Koylan N: Exercise test. (pp. 990- 992).
b) Koylan N: Ambulatory ECG ve Holter monitor(p. 992- 993).
"Clinical Sciences- 2", Ed. Kazancıgil A, Gedikoğlu G, Bayraktar K., Kros Reklamcılık ve Matbaacılık, 1991.
5. Koylan N: Cardiogenic Shock. “Emergency Internal Medicine”, 4th Print, Ed. Çalangu S, Güler K. Güzel Sanatlar Matbaası, 1995 (s. 95- 106)..
6. Koylan N: Pharmacologic research methods for antihypertensive drugs.  “Clinical Pharmacology of Antihypertensive Drugs”, Eds.  F C Tulunay, H Ergün, Klinik Farmakoloji Derneği Yayını, p. 265.
7. Koylan N: Clinical studies on prevention of Atherosclerosis and Coronary Heart Disease. “Hyperlipidemia ve Atherosclerosis”, Ed. Tokgözoğlu L, Argos İletişim, 2000, İstanbul.
8. Koylan N: Turkish Cardiology Society National Hypertension Treatment and Monitoring Guide 2000 (Author and Member of Guide Preparation Committee).
9. Koylan N: Heart failure and Angiotensin II receptor blockers.  “Angiotensin II and Angiotensin II antagonists”, Ed. K. Büyüköztürk. Print Center, 2001 (p. 75- 88).
10. a) Koylan N: Pharmacologic Treatment of Cardiac Insufficiency: Beta Receptor Blockers. "Cardiac Insufficiency", Ed. K Büyüköztürk, N Koylan. Üniform Matbaacılık, 2003 (p. 78- 85)
b) Koylan N: Refractory Heart Failure.  "Heart Failure", Ed. K Büyüköztürk, N Koylan. Üniform Matbaacılık, 2003 (p. 113- 122).
11. Koylan N. Angiotensin II receptor blockers for the treatment of heart failure.  Büyüköztürk K, Koylan N (Eds.): Angiotensin II and Angiotensin II Antagonists (2nd Print). ISBN 975-93605-2-7, Istanbul, 2005 (p.86- 97).
12. a) Koylan N: Physical examination in cardiovascular diseases (p. 23- 45). 
b) Koylan N: Precordial examination, heart sounds (p. 46- 51). 
c) Koylan N: Exercise test (p. 102- 114).
d) Koylan N: Ambulatory ECG (p. 115).
e) Koylan N: Electrocardiography based electrophysiologic examinations (p.115-117). 
f) Koylan N: Ambulatory blood pressure monitoring (p. 122- 124).
g) Koylan N: Nuclear medicine imaging methods (p. 141- 149).
"Heart Diseases—Semiology and Diagnosis Methods", Ed.: Meriç M., İstanbul Medikal Yayıncılık, ISBN 978-975- 6395- 98-1, İstanbul, 2007.
13. a) Koylan N: Physical examination in cardiovascular diseases (p. 188- 215). 
b) Koylan N: Precordial examination (p. 216- 222). 
c) Koylan N: Heart Auscultation (p. 223- 231).
d) Koylan N: Exercise test (p. 275- 285).
e) Koylan N: Ambulatory ECG monitoring methods (p. 286).
f) Koylan N: Electrocardiography based electrophysiologic examinations (p.287- 289). 
g) Koylan N: Ambulatory blood pressure monitoring (p. 298- 301).
h) Koylan N: Nuclear medicine imaging methods (p. 324- 332).
“Internal Medicine (Semiology)”, Ed. Kaysı A., Alfa Basım Yayım Dağıtım Ltd. Şti., ISBN 975- 8052- 83-7, Istanbul, 2007.
14. a) MercanoğluF, Koylan N: Approach to the cardiac patient, examination of the cardiac and circulation systems (p. 1511-1548).
b) Koylan N: Exercise test (p. 1645- 1654).
c) Koylan N: Electrocardiography based electrophysiologic examinations (p.1655- 1656). 
d) Büyüköztürk K, Koylan N: Hypertension (p. 1865- 1890).
e) Koylan N: Atherosclerosis and atherosclerotic risk factors (p.1891- 1914).
“Internal Diseases”, Ed. Büyüköztürk K, Nobel Tıp Kitabevleri Ltd. Şti., ISBN 978- 975- 420- 581- 7, Istanbul, 2007.
Articles 
1. Canberk A, Koylan N, Meriç M, Adalet I, Ekmekçi A, Ertem G: The role of atenolol in the treatment of mild and moderate hypertension.  Ist Medical School Journal., 47: 506- 514, 1984.
2. Ekmekçi A, Gören T, Meriç M, Koylan N: The research of the effect of cardioversion on serum and intracellular electrolyte levels in patients with supraventricular tachycardia.  Türk. Klin. Tıp Bil. Araşt. Der., 2: 244: 248, 1984.
3. Gürel F, Meriç M, Koylan N, Canberk A, Ekmekçi A: Progessive monitoring of changes in ventricle flexibility during acute myocardial infarction using the apexcardiogram method.   Ist Medical School Journal, 48: 11- 20, 1985.
4. Balkancı H, Ekmekçi A, Koylan N, Meriç M, Canberk A: The research of the effect of ISA activity of beta andrenoceptor blockers on carbohydrate metabolism.  Ist Medical School Journal, 48: 189- 197, 1985.
5. Koylan N, Canberk A, Meriç M, Tezer B, Ekmekçi A, Ertem G, Özcan R: The efficacy of nifedipine in hypertension as the first step medication.  Ist Medical School Journal, 48: 208- 216, 1985.
6. Koylan N, Ekmekçi A, Erdemgüler T, Çalangu S, Oral T, Meriç M, Canberk A: Comparison of the efficacy of sublingual nifedipine with intravenous furosemide in the treatment of hypertensive emergency. Ist. Medical School Journal 48: 394- 402, 1985. 
7. Koylan N, Büyüköztürk K, Meriç M, Nişancı Y, Adalet K, Deligönül U, Güven Ö, Berkmen R: Calculation of mitral valve diastolic interval area by ecocardiography:  A comparative study with heart catheterization.  Ist. Medical School Journal Mecm., 49: 9- 21, 1986.
8. Güven Ö, Adalet K, Koylan N, Berkmen R, Özkan E, Işık K, Büyüköztürk K, Ertem G, Özcan R: Risk factors, localization and complicatios in patients who experience acute myocardial infarction.  Ist. Medical School Journal Mecm., 49: 185- 193, 1986.
9. Meriç M, Koylan N, Adalet K, Şamilgil Meriç M, Ekmekçi A, Büyüköztürk K, Ertem G: Results obtained with the clinical use of prazosin in the treatment of congestive heart failure.   Istanbul Medical School 9th Congress, 22- 25 September 1987, Istanbul. Congress Book II, p.:21- 27.
10. Meriç M, Nişancı Y, Adalet K, Koylan N, Korkut F, Yaşa M, Ertem G: The importance of electrical stimulation of the heart inthe diagnosis of occult preexcitation syndrome.  A case of nodo-ventricular transmission.  Istanbul Medical School 9th Congress, 22- 25 September 1987, Istanbul. Congress Book II, p.:68- 75.
11. Meriç M, Adalet K, Ertem G, Koylan N, Karabulut N, Arseven A: A comparative clinical study of labetalol and propranolol in the treatment of essential hypertension. Istanbul Medical School 9th Congress, emergency Medicine Congress, 22- 25 September 1987, Istanbul. Congress Book III, p.:170- 181.
12. Ertem G, Akbulut T, Dişçi R, Utku F,Gürbüz Y,Tuncer O, Kütükçüler S, Yolalan ST, Koylan N, Meriç M, Canberk A, Sabuncu H, Adalet K, Okur Ö, Erzengin F, Korkut F, Nişancı Y, Güven Ö,Özsaruhan Ö, Büyüköztürk K, Özkan E, Işık K, Ekmekçi A, Berkmen R, Özcan R: The prevalence of coronary heart disease risk factors in Turkey.  İstanbul Public Health Bulletin 1:7, 1987.
13. Kazancıoğlu R, Meriç M, Adalet K, Koylan N, Ekmekçi A, Ertem G, Özcan R: The effcets of nadalol and pindolol on plasma lipoproteins in patients with essential hypertension.  The importance of symptomatic activity. 
a) Klinik Gelişim Dergisi, 1: 261- 267, 1988.
b) Sandoz Ürünleri Ltd. Şti. İlaç Bölümü, 1988, İstanbul.
14. Uslubaş S, Meriç M, Adalet K, Koylan N, Nişancı Y, Büyüköztürk K, Berkmen R, Ertem G, Özkan E: Examination of serum lipid levels in patients with chronic cor pulmonale.  Ist. Medical School Journal, 51: 25- 32, 1988.
15. Boztaş G, Adalet K, Ekmekçi A, Meriç M, Koylan N, Korkut F, Canberk A, Ertem G, Özcan R: Investigation of intra-erythrocyte fluid volumes in children with normal blood pressure in families with essential hypertension.  Ist. Medical School Journal, 52: 555- 566, 1989.
16. Meriç M, Nişancı Y, Adalet K, Gören T, Umman S, Atılgan D, Koylan N, Onursal E, Büyüköztürk K, Ertem G: The results and complications of percutaneous transluminal coronary angioplasty treatment in ischemic heart disease.  Ist. Medical School Journal, 53 (3): 1- 14, 1990.
17. Umman S, Atılgan D, Gören T, Nişancı Y, Umman B, Koylan N, Adalet K, Öncül A, Meriç M, Özcan R: The investigation of the effect of 10 mg sublingual nifedipine on the cardiovascular system in hypertrophic  obstructive cardiomyopathy.   Ist. Medical School Journal, 53 (4): 1- 10, 1990.
18. Atılgan D, Gören T, Umman S, Koylan N, Adalet K, Meriç M, Nişancı Y, Berkmen R: A rare case of hypertrophic cardiomyopathy and homozygous familial hypercholesterolemia.  Ist. Medical School Journal, 53 (4): 131- 140, 1990.
19. Meriç M, Nişancı Y, Adalet K, Gören T, Umman S, Atılgan D, Koylan N, Onursal E, Barlas C, Korkut F, Güven Ö, Özsaruhan Ö, Erzengin F, Özcan R, Ertem G, Büyüköztürk K, Berkmen R: The role of percutaneous transluminal coronary angioplasty in unstable angina pectoris.  Türk Kardiyol. Dern. Arş. 18: 124- 128, 1990.
20. Meriç M, Nişancı Y, Gören T, Adalet K, Umman S, Atılgan D, Koylan N, Barlas C, Korkut F, Güven Ö, Özcan R, Ertem G, Büyüköztürk K, Berkmen R: The results of percutaneous transseptal valvuloplasty with balloon catheter in mitral stenosis due to acute rheumatic fever.  Klinik Gelişim 3: 714- 718, 1990.
21. Canberk A, Gönçoğlu H, Koylan N: Plasma lipid fractions in patients with essential hypertension.  Türk Tıp Der Der 56: 312- 317, 1990.
22. Atılgan D, Koylan N, Adalet K,Gören T, Umman S, Meriç M: The acute effect of aminophyllin on exercise capacity in patients with stable angina pectoris.  Türk Tıp Der Der 9:409- 414, 1990.
23. Nişancı Y, Özsaruhan Ö, Adalet K, Umman S, Meriç M, Atılgan D, Koylan N, Gören T, Ertem G, Özcan R: The long-term follow-up results of antitachycardia pacemakers.  Türk Kardiyol Dern Arş 19: 54- 57, 1991.
24. Nişancı Y, Deligönül U, Alatlı C, Erbengi T, Umman S, Adalet K, Koylan N, Gören T, Atılgan D, Meriç M, Erseven G, Ertem G: Our results with transvenous endomyocardial biopsy.  Türk Kardiyol Dern Arş 19: 58- 62, 1991.
25. Gören T, Kaymaz C, Nişancı Y, Adalet K, Koylan N, Meriç M: The importance of ST segment elevation during exercise test (due to a case).  Türk Klin Kardiyol 4:145- 148, 1991.
26. Koylan N, Canberk A, Atılgan D, Özbey N, Gören T, Umman S, Büyüköztürk K, Ertem G: Plasma Endothelin-1 levels in hypertensive and healthy people.  Ist. Medical School Journal 55: 397- 404, 1992.
27. Atılgan D, Koylan N, Umman S, Gören T, Meriç M: The effect of atropin on ventricular arrhythmias that occur during coronary arteriography.  Ist. Medical School Journal 55: 1- 6, 1992.
28. Koylan N, Mercanoğlu F, Orak E, Erzengin F, Büyüköztürk K: Acute effects of Cilazapril on left ventricular diastolic functions in essential hypertension.  Türk Klin Kardiyol 7: 17- 20, 1994.
29. Koylan N, Atılgan D, Canberk A, Buğra Z, Ünlüer O, Vural A, Büyüköztürk K: Examination of signal-averaged electrocardiogram findings in patients with mild and moderate essential hypertension.  Türk Klin Kardiyol 7(3): 133- 136, 1994.
30. Meriç M, Adalet K, Nişancı Y, Umman S, Koylan N, Gören T, Mercanoğlu F, Buğra Z, Öncül A, Helvacı A, Umman B, Büyüköztürk K, Ertem G: The comparison of conventional and magnum magnarail angioplasty methods in the treatment of chronic total coronary artery occlusion.  Türk Kardiyol Dern Arş 22: 224- 228, 1994.
31. Buğra Z, Koylan N, Okur Ö, Öncül A, Vural A, Ünlüer O, Büyüköztürk K: Ventricular late potentials in healthy individuals.  Türk Kardiyol Dern Arş 22: 246- 248, 1994.
32. Buğra Z, Meriç M, Koylan N, Adalet K, Nişancı Y, Büyüköztürk K, Ertem G: Long-term effects of coronary angioplasty on ventricular late potentials.  MN Kardiyoloji 1: 14- 19, 1994.
33. Meriç M, Nişancı Y, Adalet K, Umman S, Gören T, Koylan N, Yılmaz E, Buğra Z, Öncül A, Orak E, Büyüköztürk K, Ertem G: Correlation of combined diagnostic coronary arteriography and angioplasty with elective coronary angioplasty.   T Klin Kardiyol 7: 31- 34, 1994.
34. Yılmaz E, Nişancı Y, Meriç M, Yılmaz G, Koylan N,Adalet K, Buğra Z, Büyüköztürk K, Ertem G: Troponin T levels in patients with stable angina pectoris who have underwent percutaneous transluminal coronary angioplasty.  Türk Kardiyol Dern Arş 23: 198- 202, 1995.
35. Adalet I, Adalet K, Heper C, Şirali C, Orak E, Buğra Z, Koylan N, Ertem G, Büyüköztürk K, Cantez S: Evaluation of the effects of captopril and benazepril on left ventricular functions in patients with essential hypertension using radionuclide ventriculography:   A double-blind comparative study.  T Klin Kardiyol 8: 72- 77, 1995.
36. Yılmaz E, Ağaçfidan A, Yılmaz G, Umman B, Mercanoğlu F, Koylan N, Adalet K, Öncül A, Badur S, Nişancı Y, Meriç M: Can chlamydia pneumoniae infection be a new risk factor in patients with coronary heart  disease?  T Klin Kardiyol 8: 146- 148, 1995.
37. Koylan N: The efficacy and safety of Simvastatin in the treatment of hypercholesterolemia. MN Kardiyol 3:222- 228.
38. Helvacı A, Meriç M, Koylan N, Erzengin F, Gören T, Umman S, Büyüköztürk K, Ertem G. Examination of Left Atrial Appendiceal Flows Before and After Percutaneous Mitral Valvotomy in patients with Mitral Stenosis.   Türk Kardiyol Dern Arş 1997; 25:0-0
39. Mercanoğlu F, Karşıdağ K, Oflaz H, Alo F, Koylan N, Erzengin F, Büyüköztürk K, Ertem G. Left Ventricular Diastolic Functions in Normotensive Patients with Type II Diabetes Mellitus Diagnosed Recently.   Türk Kardiyol Dern Arş 1997; 25:0-0.
40. Mercanoğlu F, Oflaz H, Yılmaz E, Umman S, Küçükbasmacı Ö, Koylan N, Büyüköztürk K: Comparison of the value of fast, qualitative troponin T assay and quantitative troponin T analysis in the diagnosis of acute myocardial infarction.  Türk Kardiyol Dern Arş 27: 98- 103, 1999.
41. Büyüköztürk K, İlerigelen B, Kabakçı G, Koylan N, Kozan Ö: A comprehensive study for the determination of risk profiles in hypertensive patients in Turkey.  I.C.E.B.E.R.G. Study. Türk Kardiyol Der Arş 32(6): 344- 349, 2004
42. Topbaş A, Bilge AK, Biricik FS, Kocaman O, Oflaz H, Soyluk Ö, Koylan N: The effect of losartan on plasma prolactin, cortisol and TSH levels in patients with mild and moderate essential hypertension.  Ist. Medical School Journal 67(4):224- 228, 2004.
43. Kabakcı G, Koylan N, İlerigelen B, Kozan Ö, Büyüköztürk K. The effect of dyslipidemia on cardiovascular risk classification of hypertensive patients and the relationship of lipid profile with other cardiovascular risk factors.   Results from ICEBERG study. Türk Kardiyol Dern Arş 2007; 35:458-466
Compilations in Turkish.
1. Koylan N: Diabetic Retinopathy.  Ist. Medical School Journal, 4: 242- 250, 1980.
2. Ekmekçi A, Meriç M, Koylan N: Beta adrenoceptor blockers (Clinical pharmacology and side effects). Türkiye Klinikleri, 2: 9- 18, 1982.
3. Berkmen R, Ekmekçi A, Meriç M, Koylan N: Calcium Antagonists. Ist. Medical School Journal, 46: 164- 172, 1983.
4. Ekmekçi A, Koylan N, Meriç M: Calcium Antagonists. Doğu İlaç Fabrikası A. Ş., September 1983, Istanbul.
5. Ekmekçi A, Meriç M, Koylan N: The role of surgical treatment in coronary heart disease.  Sandoz İlaç Sanayi Ltd. Şti., Orhanlar Matbaası, 1983, İstanbul.
6. Ekmekçi A, Canberk A, Meriç M, Koylan N, Nişancı Y: The epidemiology of hypertension.  Ciba Tıbbi Yay›nlar Dizisi, 1984, İstanbul.
7. Ekmekçi A, Canberk A, Meriç M, Koylan N, Nişancı Y: Pathophysiology and pathogenesis of primary hypertension.  Ciba Tıbbi Yayınlar Dizisi, 1984, İstanbul.
8. Ekmekçi A, Canberk A, Meriç M, Koylan N, Boztaş G: The hemodynamic, metabolic and clinical importance of partial agonist activity (ISA) in beta-adrenoceptor blockers.  Sandoz İlaç Sanayi Ltd. Şti., Orhanlar Matbaası, 1984, İstanbul.
9. Ekmekçi A, Cantez T, Canberk A, Meriç M, Koylan N: The role and disadvantages of diuretics in the treatment of hypertension.  Servier- Ali Raif İlaç Sanayii, 1984, İstanbul.
10. Ekmekçi A, Cantez T, Canberk A, Meriç M, Koylan N, Tezer B: Vasodilatation treatment and the role of adrenoceptor blockers in hypertension.  Pfizer Araştırmalar Dizisi 1, 1985, İstanbul.
11. Koylan N, Meriç M, Atılgan D: A new option in nitrate therapy:  Mononitrates. Ist. Medical School Journal 53: 163- 168, 1990 .
12. Meriç M, Koylan N: Diuretic and their use in hypertension treatment.  Türk Tıp Der Der 56: 97- 102, 1990.
13. Meriç M, Koylan N: Calcium antagonists. Türk Tıp Der Der 56: 124- 131, 1990.
14. Meriç M, Koylan N, Şamilgil Meriç M: Percutaenous transluminal atherectomy. Ist. Medical School Journal 54: 331- 336, 1991.
15. Kaymaz C, Koylan N, Meriç M: Reperfusion damage. Ist. Medical School Journal 54: 507- 512, 1991.
16. Koylan N: Hypertension, atherosclerosis, hyperinsulinemia and syndrome  X. Medikal Magazin 92: 45- 46, 1993.
17. Mercanoğlu F, Koylan N: A different mechanism in the treatment of ischemic heart disease - K+ channel activation and nicorandil. Türk Kard Dern Arş 22: 43- 48, 1994.
18. Kaymaz C, Koylan N: Heart rate variability. Ist. Medical School Journal 57: 111-114, 1994.
19. Buğra Z, Koylan N: The importance of exercise test in the monitoring and treatment of heart failure.  Türk Klin Kardiyol 7: 55- 57, 1994.
20. Umman B, Koylan N: A new step in hypertension therapy:  Angiotensin II antagonists. Türk Klin Kardiyol 9: 118- 122, 1996.
21. Umman B, Koylan N: Oxyfen free radicals and their clinical importance in cardiology.  Ist. Medical School Journal (in print). 
22. Umman B, Koylan N: The metabolic dimension in hypertension.  Hipokrat 51: 10- 16, 1996.
23. Umman B, Koylan N: Hypertension and left ventricular hypertrophy. Hipokrat 51: 17- 23, 1996.
24. Koylan N: New risk factors in atherosclerosis: Low HDL, hypertriglyceridemia and hyperhomocysteinemia. Hipokrat Kardiyoloji 1(4): 23- 28, 1997.
25. Umman B, Koylan N: Angiotensin II receptors and antagonists. AII Council Bulletin 1(1): 3, 1997.
26. Koylan N, Mercanoğlu F: The role of calcium antagonists in hypertension therapy.  Hipokrat 71: 7-11, 1998.
27. Koylan N: Lipoprotein (a) and its secrets. British Medical Journal 4(4): 8- 9, 1999.
28. Koylan N: Lipoprotein (a) and atherosclerosis. Turkish Cardiology Society Archives, 27(8):  483- 490, 1999.
29. Mercanoğlu F, Koylan N: Neurohumoral mechanisms in heart failure. AII Council Bulletin 3(1): 58- 60, 1999.
30. Koylan N: Essential hypertension and cell membrane. Folia 1(1): 17- 22, 2000.
31. Koylan N: Clinical studies on prevention of Atherosclerosis and Coronary Heart Disease. Türkiye Tıp Dergisi 7(1): 40- 47, 2000.
32. Koylan N: The epidemiology of coronary heart disease, large clinical studies related to lipid-lowering therapy.   Türkiye Klinikleri Kardiyoloji, 13(1- Suppl. 1): 9- 20, 2000.
33. Koylan N: Large clinical studies on prevention of Atherosclerosis and Coronary Heart Disease. Türkiye Klinikleri Kardiyoloji, 13(1- Suppl. 1): 21- 21- 28, 2000.
34. Koylan N: Exercise test and nuclear cardiologic diagnosis methods used in the diagnosis of ischemic heart disease.   Hipokrat Kardiyoloji 4(13): 8- 17, 2000.
35. Koylan N: Sildenafil and Cardiovascular system.  Andrology Bulletin 3: 4-5, 2000.
36. Koylan N: Risk detecion after acute myocardial infarction and invidual approach to the treatment of chronic heart disease.  Türkiye Klinikleri Kardiyoloji 13 (4- Ek 1): 23- 30, 2000.
37. Koylan N: Hypertension and endothelium.  Türkiye Klinikleri Kardiyoloji 13 (5): 333- 336, 2000.
38. Koylan N: Individual risk detection in hypertension accompanied by guidelines.  AII Council Bulletin 4(1): 8- 10, 2000.
39. Koylan N: Turkish society and the increasing trend of coronary heart disease.  Turkish Cardiology Society Archives.   29:610-611, 2001.
40. Koylan N: Diabetes and hypertension.  Avicena 2(9): 6-11, 2001.
41. Koylan N: Hypertension and cognitive function.  AII Council Bulletin 5(1): 11- 13, 2001.
42. Koylan N: Hypertension and ACE inhibitors, Turkish Cardiology Seminars 2(2):165- 174, 2002.
43. Koylan N: Cardiovascular Diseases and Diet. Actual Medicine 10(3): 40-46, 2002.
44. Koylan N: Clinical researches and clinical evidences.  AII Council Bulletin 6(1): 7-9, 2002.
45. Koylan N: Clinical researches and evidence-based medicine terminology.   AII Council Bulletin 6(2): 28- 30, 2002.
46. Koylan N: Targets in the treatment of hypertension and LIFE trial.   AII Council Bulletin 6(3): 37- 40, 2002.
47. Koylan N: Blood pressure monitoring at home.  AII Council Bulletin 7(3): 38- 44, 2003.
48. Mercanoğlu F, Koylan N: Cardiology consultation prior to non-cardiac surgery.  Kardiyaktuel 1(1): 8- 12, 2003.
49. Koylan N: Angiotensin II and atherosclerosis. Kardiyaktuel 1(3): 14- 19, 2003.
50. Koylan N: Atrial fibrillation and hypertension. AII Council Bulletin 8(1): 1- 5, 2004.
51. Koylan N: Diabetes, hypertension and cardiovascular risk. Diabetes Forum 1(1-2): 29- 34, 2004.
52. Koylan N: Diabetes, hypertension and cardiovascular risk. AII Council Bulletin 8(2): 17- 22, 2004.
53. Koylan N: Angiotensin II and Cardiovascular System.  Turkish Cardiology Seminars 4(3):  264- 272, 2004.
54. Koylan N: Refractory heart failure.  Türkiye Klinikleri Kardiyoloji 17(2): 89- 96, 2004.
55. Koylan N: Isolated systolic hypertension as a cardiovascular risk factor.   AII Council Bulletin 6(3): 34- 38, 2004.
Papers in Turkish 
1. Ekmekçi A, Meriç M, Koylan N: Calcium Antagonists. Gevher Nesibe Science Week and Medicine Days, 11- 13 March 1982, Kayseri. Book of Proceedings, p:  732- 748.
2. Berkmen R, Ekmekçi A,  Meriç M, Koylan N: Calcium Antagonists. Turkish Cardiology Society IIIrd Post-graduation Training Course 19-22 April 1982, Istanbul. 
3. Özcan M, Ekmekçi A, Koylan N, Meriç M, Özcan R, Berkmen R, Büyüköztürk K, Ertem G, Işık K: The effect of aspirin on regular serum digoxin levels.  IIIrd National Cardiology Congress, 24- 27 October 1982, Ankara. Book of Proceedings, p.:  123.
4. Gürel F, Koylan N, Meriç M, Nişancı Y, Orhan Y, Deligönül U, Ekmekçi A, Büyüköztürk K, Ertem G, Berkmen R, Işık K, Özkan E, Özcan R: Monitoring of ventricular compliance changes in the course of acute myocardial infarction using apexcardiogram.   Istanbul Medical School 7th Congress, Free Papers, 25- 29 September 1983, Istanbul. Book of Proceedings, p.:  91, Paper no: 161.
5. Yalçın F, Koylan N, Meriç M, Deligönül U, Nişancı Y, Ekmekçi A, Büyüköztürk K, Ertem G, Berkmen R, Işık K, Özkan E, Özcan R: Examination of changes in ventricular performance in acute myocardial infarction using apexcardiogram.   Istanbul Medical School 7th Congress, Free Papers, 25- 29 September 1983, Istanbul. Book of Proceedings, p.:  92, Paper no: 163.
6. Özbek H, Koylan N, Meriç M, Nişancı Y, Deligönül U, Ekmekçi A, Büyüköztürk K, Ertem G, Berkmen R, Işık K, Özkan E, Özcan R: Investigation of erythrocyte membrane ATPase activities in young age myocardial infarctions.   Istanbul Medical School 7th Congress, Free Papers, 25- 29 September 1983, Istanbul. Book of Proceedings, p.:  93, Paper no: 164.
7. Güven Ö, Koylan N, Meriç M, Nişancı Y, Deligönül U, Ekmekçi A, Büyüköztürk K, Ertem G, Berkmen R, Işık K, Özkan E, Özcan R: The effect of aspirin on regular serum digoxin level.  Istanbul Medical School 7th Congress, Free Papers, 25- 29 September 1983, Istanbul. Book of Proceedings, p.:  93, Paper no: 165.
8. Ferhanoğlu B, Koylan N, Meriç M, Canberk A, Nişancı Y, Ekmekçi A, Deligönül U, Büyüköztürk K, Berkmen R, Ertem G, Işık K, Özkan E, Özcan R: Changes in erythrocyte fluid volume in essential hypertension.  Istanbul Medical School 7th Congress, Free Papers, 25- 29 September 1983, Istanbul. Book of Proceedings, p.:  94, Paper no: 166.
9. Gören T, Koylan N, Nişancı Y, Meriç M, Deligönül U, Ekmekçi A, Büyüköztürk K, Berkmen R, Ertem G, Işık K, Özkan E, Özcan R: The effect of cardioversion on serum and intracellular electrolyte levels in patients with supraventricular tachycardia.  Istanbul Medical School 7th Congress, Free Papers, 25- 29 September 1983, Istanbul. Book of Proceedings, p.:  96, Paper no: 169.
10. Canberk A, Meriç M, Koylan N, Ertem G, Ekmekçi A: Drugs and treatment principles used in the treatment of primary hypertension, pathophysiology and pathogenesis.  Istanbul Medical School 7th Congress, Symposium on New Developments in the Treatment of Cardiovascular Diseases, 25- 29 September 1983, Istanbul. Symposium Book, p:  91- 94.
11. Uluğlar L, Sandalcı Ö, Ekmekçi A, Azizlerli H, Meriç M, Alagöl F, Koylan N, Berker F: The effect of cardioversion on serum prolactin, growth hormone and cortisole levels in patients with supraventricular tachycardia.  IVth National Cardiology Congress, 9- 12 October 1984, İzmir. Book of Proceedings, p.:  16.
12. Koylan N, Canberk A, Tezer B, Ekmekçi A, Ertem G, Özcan R: Examination of the antihypertensive action obtained by combining beta blockers and indapamide.  IVth National Cardiology Congress, 9- 12 October 1984, İzmir. Book of Proceedings, p.:  38.
13. Koylan N, Canberk A, Tezer B, Adalet I, Meriç M, Ekmekçi A, Ertem G: Investigation of the antihypertensive action of pindolol-nifedipine combination.  IVth National Cardiology Congress, 9- 12 October 1984, İzmir. Book of Proceedings, p.:  40.
14. Canberk A, Koylan N, Meriç M, Adalet I, Ekmekçi A, Koyuncuoğlu H, Ertem G: The role of atenolol in the treatment of mild and moderate hypertension.  IVth National Cardiology Congress, 9- 12 October 1984, İzmir. Book of Proceedings, p.:  41.
15. Koylan N, Canberk A, Meriç M, Ekmekçi A, Ertem G, Özcan R: Investigation of the antihypertensive action of exprenolol retard in patients with essential hypertension.  IVth National Cardiology Congress, 9- 12 October 1984, İzmir. Book of Proceedings, p.:  42.
16. Özkan E, Koylan N, Öner A, Çakaloğlu Y, Meriç M, Korkut F, Büyüköztürk K: Investigation of the effects atenolol on hemostasis through thrombin and partial thromboplastin times.  IVth National Cardiology Congress, 9- 12 October 1984, İzmir. Book of Proceedings, p.:  90.
17. Balkancı H, Koylan N, Meriç M, Canberk A, Ekmekçi A: The research of the effect of ISA activity of beta andrenoceptor blockers on carbohydrate metabolism.  IVth National Cardiology Congress, 9- 12 October 1984, İzmir. Book of Proceedings, p.:  91.
18. Koylan N, Canberk A, Meriç M, Tezer B, Ekmekçi A, Ertem G, Özcan R: The efficacy of nifedipine in hypertension as the first step medication.  IVth National Cardiology Congress, 9- 12 October 1984, İzmir. Book of Proceedings, p.:  93.
19. Özkan E, Koylan N: The role and importance of surgical treatment in ischemic heart disease.  Bezm-i Alem Valide Sultan Vakıf Gureba Hastanesi The 3rd Prof. E. Frank Commemoration Day Panels – A Panel on The Present Status of Coronary Surgery, 13 November 1985, Istanbul. Panel Book, p:  37- 45.
20. Canberk A, Erbengi T, Canberk Y, Ertem G, Tezer B, Koylan N: Ultrastructural examination of erythrocytes in patinets with primary hypertension.  Istanbul Medical School 8th Congress, Electromicroscopy Congress, 16- 20 September 1985, Istanbul. Congress Book, p:  68.
21. Güven Ö, Koylan N, Özkan E, Büyüköztürk K, Ertem G, Berkmen R, Işık K, Özsaruhan Ö, Özcan R: Risk factors, localization and complicatios in patients who experience acute myocardial infarction.  Istanbul Medical School 8th Congress, Emergency Medicine Congress, 16- 20 September 1985, Istanbul. Congress Book, p:  287.
22. Güven Ö, Koylan N, Özkan E, Berkmen R, Işık K, Büyüköztürk K, Ertem G, Özcan R: The frequency of intraventricular transmission disorders in the course of acute myocardial infarction and its relationship with the localization of infraction.  Istanbul Medical School 8th Congress, Emergency Medicine Congress, 16- 20 September 1985, Istanbul. Congress Book, p:  288.
23. Koylan N, Güven Ö, Okur Ö, Özkan E, Büyüköztürk K, Ertem G, Işık K, Berkmen R, Özcan R: The frequency of atrioventricular transmission disorders in the course of acute myocardial infarction and its relationship with the localization of infraction.  Istanbul Medical School 8th Congress, Emergency Medicine Congress, 16- 20 September 1985, Istanbul. Congress Book, p:  289.
24. Koylan N, Güven Ö, Okur Ö, Özkan E, Büyüköztürk K, Berkmen R, Ertem G, Işık K, Özsaruhan Ö, Özcan R: The correlation of early mortality in patients with acute myocardial infarction with various factors.   Istanbul Medical School 8th Congress, Emergency Medicine Congress, 16- 20 September 1985, Istanbul. Congress Book, p:  290.
25. Koylan N, Ekmekçi A, Erdemgüler T, Çalangu S, Oral T, Oral T, Meriç M, Canberk A: Comparison of the efficacy of sublingual nifedipine with intravenous furosemide in hypertensive emergency cases. Istanbul Medical School 8th Congress, Emergency Medicine Congress, 16- 20 September 1985, Istanbul. Congress Book, p:  291.
26. Güven Ö, Koylan N, Berkmen R, Ertem G, Büyüköztürk K, Işık K, Özkan E, Özcan R: Investigation of the effects of morphine on coronary sinus blood flow and coronary resistance.  1985 Cardiology Meeting organized jointly by Turkish Cardiology Society and Dicle University, 9- 12 October 1985, Diyarbakır. Turkish Cardiology Society Archives, No:   14, s.: 13, 1986.
27. Levi S, Büyüköztürk K, Meriç M, Koylan N, Erzengin F, Özsaruhan Ö, Özkan E, Özcan R: Investigation of the acute effects of verapamil in essential hypertension using bloodless methods.  Vth National Cardiology Congress, 5- 8 November 1986, Istanbul. Book of Proceedings, p.:  16- 17.
28. Güven Ö, Adalet K, Koylan N, Berkmen R, Özkan E,  Işık K, Büyüköztürk K, Ertem G, Özsaruhan Ö, Özcan R: Risk factors, localization and complications in patients who experience acute myocardial infarction.  Vth National Cardiology Congress, 5- 8 November 1986, Istanbul. Book of Proceedings, p.:  23- 24.
29. Seyithanoğlu BY, Ekmekçi A, Meriç M, Adalet K, Koylan N, Korkut F, Ertem G, Özcan R: The role and importance of serum F/FDP rate in the determination of in-hospital prognosis after acute myocardial infarction.  Vth National Cardiology Congress, 5- 8 November 1986, Istanbul. Book of Proceedings, p.:  24- 25.
30. Koylan N, Büyüköztürk K, Meriç M, Deligönül U, Nişancı Y, Erzengin F, Güven Ö, Berkmen R: Calculation of diastolic interval area of the mitral valve in pure mitral stenosis using M-mode echocardiography and comparison with hemodynamic finding.  Vth National Cardiology Congress, 5- 8 November 1986, Istanbul. Book of Proceedings, p.:  44- 45.
31. Uslubaş S, Özkan E, Meriç M, Adalet K, Koylan N, Nişancı Y, Büyüköztürk K, Berkmen R, Ertem G, Özcan R: Examination of resum lipid levels in patients with chronic cor pulmonale.  Vth National Cardiology Congress, 5- 8 November 1986, Istanbul. Book of Proceedings, p.:  60.
32. Ertem G, Akbulut T, Dişçi R, Utku T, Gürbüz Y, Tuncer O F, Kütükçüler N, Yolalan S T, Koylan N, Meriç M, Canberk A, Sabuncu H, Adalet K, Okur Ö, Erzengin F, Korkut F, Nişancı Y, Güven Ö, Özsaruhan Ö, Büyüköztürk K, Özkan E, Berkmen R, Ekmekçi A, Özcan R: The prevalence of coronary heart disease risk factors in Turkey.  I- Hypertension- Blood pressure screening in patients. Vth National Cardiology Congress, 5- 8 November 1986, Istanbul. Book of Proceedings, p.:  65.
33. Kazancıoğlu R, Ekmekçi A, Meriç M, Adalet K, Koylan N, Korkut F, Canberk A, Ertem G, Özcan R: The effects of beta blockers in plasma lipid fractions and the importance of ISA in essential hypertension.  Vth National Cardiology Congress, 5- 8 November 1986, Istanbul. Book of Proceedings, p.:  90- 91.
34. Boztaş G, Ekmekçi A, Meriç M, Adalet K, Koylan N, Korkut F, Canberk A, Ertem G, Özcan R: Investigation of intra-erythrocyte fluid volumes in children with normal blood pressure in families with primary hypertension.  Vth National Cardiology Congress, 5- 8 November 1986, Istanbul. Book of Proceedings, p.:  91.
35. Meriç M, Adalet K, Ertem G, Koylan N, Karabulut N, Arseven A: A comparative clinical study of labetalol and propranolol in the treatment of essential hypertension. Istanbul Medical School 9th Congress, 22- 25 September 1987, Istanbul.
36. Meriç M, Nişancı Y, Adalet K, Koylan N, Korkut F, Yaşa M, Ertem G: The importance of electrical stimulation of the heart inthe diagnosis of occult preexcitation syndrome.  A case of nodo-ventricular transmission.  Istanbul Medical School 9th Congress, 22- 25 September 1987, Istanbul.
37. Meriç M, Koylan N, Adalet K, Şamilgil M, Ekmekçi A, Büyüköztürk K, Ertem G: Results obtained with the clinical use of prazosin in the treatment of congestive heart failure.   Istanbul Medical School 9th Congress, 22- 25 September 1987, Istanbul.
38. Erzengin F, İnanç M, Büyüköztürk K, Adalet K, Umman S, Atılgan D, Gören T, Koylan N, Nişancı Y, İnanç S, Öncül A: An interesting case of left ventricular aneurysm showing wall dissection. VIIth National Cardiology Congress, 26- 30 May 1990, İzmir. Türk Kardiyol Dern Arş VIIth National Cardiology Conrgess, Book of Proceedings Volume, Paper no: 205.
39. Umman S, Nişancı Y, Özsaruhan Ö, Adalet K, Kargı A, Gören T, Koylan N, Güven Ö, Barlas C: An interesting case of arteriovenous fistula causing congestive heart failure.   VIIth National Cardiology Congress, 26- 30 May 1990, İzmir. Türk Kardiyol Dern Arş VIIth National Cardiology Conrgess, Book of Proceedings Volume, Paper no: 238.
40. Adalet K, Meriç M, Nişancı Y, Onursal E, Gören T, Koylan N, Özcan R, Ertem G, Büyüköztürk K, Berkmen R: Percutaneous transluminal coronary angioplasty in unstable angina pectoris.  VIIth National Cardiology Congress, 26- 30 May 1990, İzmir. Türk Kardiyol Dern Arş VIIth National Cardiology Congress, Book of Proceedings Volume, Paper no: 300.
41. Canberk A, Koylan N, Yıldıran G, Ertem G, Özcan R, Ekmekçi A: Enalapril in the treatment of essential hypertension. 1st National Hypertension Congress with International Participation and ACE Inhibitors  Symposium, 10- 12 October 1990, Adana. Congress Book, p. 38. 
42. Yılmaz E, Adalet K, Yılmaz G, Badur S, Erzengin F, Koylan N, Özsaruhan Ö, Çetin ET, Büyüköztürk K: The importance of serum anticardiolipin levels in coronary heart disease:  A preliminary study. 
a) 1991 Cardiology Meeting, 10- 23 September 1991, Trabzon. Türk Kardiyol Dern Arş 1991 Cardiology Meeting, Book of Proceedings Volume, Paper no: 39.
b) Istanbul Medical School 11th Congress, 22- 25 September 1991, Istanbul. Abstract book, p. 85. 
43. Koylan N, Canberk A, Atılgan D, Özbey N, Gören T, Umman S, Büyüköztürk K, Ertem G: Plasma Endothelin-1 levels in healthy and hypertensive people. 
a) 1991 Cardiology Meeting, 10- 23 September 1991, Trabzon. Türk Kardiyol Dern Arş 1991 Cardiology Meeting, Book of Proceedings Volume, Paper no: 68.
b) Istanbul Medical School 11th Congress, 22- 25 September 1991, Istanbul. Abstract book, p. 83. 
44. Adalet K, Koylan N, Atılgan D, Adalet I, Erzengin F, Ertem G, Büyüköztürk K: Comparison of the effects of oral gallopamil and nifedipine in stable angina pectoris – A placebo-controlled, double-blind, randomized, cross-study.
a) 1991 Cardiology Meeting, 10- 23 September 1991, Trabzon. Türk Kardiyol Dern Arş 1991 Cardiology Meeting, Book of Proceedings Volume, Paper no: 149.
b) Istanbul Medical School 11th Congress, 22- 25 September 1991, Istanbul. Abstract book, p. 84. 
45. Erzengin F, Büyüköztürk K, Umman S, Buğra Z, Öncül A, Adalet K, Koylan N, Ertem G: Examination of left ventricular diastolic functions using Doppler Echocardiography and comparison with hemodynamic findings.  
a) 1991 Cardiology Meeting, 10- 23 September 1991, Trabzon. Türk Kardiyol Dern Arş 1991 Cardiology Meeting, Book of Proceedings Volume, Paper no: 222.
b) Istanbul Medical School 11th Congress, 22- 25 September 1991, Istanbul. Abstract book, p. 82. 
46. Adalet K, Koylan N, Buğra Z, Umman B, Öncül A, Ertem G: The efficacy of felodipine, a long-acting calcium antagonist, in patients with mild or moderate essential hypertension.  A single-blind, placebo-controlled study.  Istanbul Medical School 11th Congress, 22- 25 September 1991, Istanbul. Abstract book, p. 87. 
47. Adalet I, Özbey N, Adalet K, Buğra Z, Koylan N, Erzengin F, Meriç M, Nişancı Y, Özsaruhan Ö, Cantez S, Görpe A, Büyüköztürk K, Ertem G: The evaluation of development of functional left ventricular aneurysm in the course of acute anterior transmural myocardial infarction using non-invasive methods.  IInd National Echocardiography Congress, 8-10 October 1991, Antalya Abstract Book, Paper No:  O28.
48. Tutar A, Gören T, Nişancı Y, Umman S, Yılmaz E, Umman B, Kaymaz C, Erzengin F, Adalet K, Koylan N, Meriç M, Büyüköztürk K, Ertem G: The effect of heart rate on Doppler measurements in mitral stenosis cases:  A study performed with transesophageal "atrial pacing". National Echocardiography Congress, 8-10 October 1991, Antalya Abstract Book, Paper No:  O66.
49. Adalet K, Kaymaz C, Deymeer F, Koylan N, Erzengin F, Özdemir C, Büyüköztürk K, Ertem G: Determination of cardiovascular anomalies using echocardiography in patients with Duchenne Muscular Dystrophy. IInd National Echocardiography Congress, 8-10 October 1991, Antalya Abstract Book, Paper No:  O67.
50. Özbey N, Adalet K, Adalet I, Koylan N, Erzengin F, Ertem G, Büyüköztürk K: The relationship of dangerous ventricular arrythmias occurring in the course of acute myocardial infraction with ventricular late potentials.  VIIIth National Cardiology Congress, 27 September- 1 October 1992, Istanbul. Abstract book, p:  32.
51. Gören T, Atılgan D, Umman S, Eren N, Çubukçu A, Koylan N, Meriç M: The cardiac and systemic effects of long-acting isradipine treatment in patients with mild or moderate essential hypertension.  VIIIth National Cardiology Congress, 27 September- 1 October 1992, Istanbul. Abstract book, p:  48.
52. Meriç M, Adalet K, Nişancı Y, Umman S, Koylan N, Gören T, Büyüköztürk K, Ertem G: Coronary atherectomy results (due to 7 patients). VIIIth National Cardiology Congress, 27 September- 1 October 1992, Istanbul. Abstract book, p:  51.
53. Kaymaz C, Nişancı Y, Umman S, Gören T, Öncül A, Helvacı A, Erzengin F, Koylan N, Meriç M, Özsaruhan Ö, Büyüköztürk K, Ertem G: The relationship between late potentials and mitral stenosis in cases with primary mitral prolapse.  VIIIth National Cardiology Congress, 27 September- 1 October 1992, Istanbul. Abstract book, p:  69, Paper no: 300.
54. Umman B, Meriç M, Umman S, Koylan N, Adalet K, Nişancı Y, Ertem G: The effect of coronary angioplasty performed on left anterior descending artery lesion on left ventricular global and local functions in patients with angina pectoris after anterior wall myocardial infarction.   IXth National Cardiology Congress, 28 September- 1 October 1993, Bursa. Abstract Book, p.:  17, Paper no: 61.
55. Meriç M, Nişancı Y, Adalet K, Umman S, Gören T, Koylan N, Orak E, Buğra Z, Yılmaz E, Büyüköztürk K, Ertem G: Correlation of combined diagnostic coronary arteriography and angioplasty with elective coronary angioplasty.   IXth National Cardiology Congress, 28 September- 1 October 1993, Bursa. Abstract Book, p.:  31, Paper no: 135.
56. Meriç M, Adalet K, Nişancı Y, Umman S, Koylan N, Gören T, Helvacı A, Mercanoğlu F, Umman B, Büyüköztürk K, Ertem G: The comparison of conventional method and magnum magnarail system with angioplasty in the treatment of total coronary artery occlusion.  IXth National Cardiology Congress, 28 September- 1 October 1993, Bursa. Abstract Book, p.:  31, Paper no: 136.
57. Çefle K, Adalet K, Koylan N, Okur Ö, Orak E, Helvacı A, Mercanoğlu F, Meriç M, Ertem G, Büyüköztürk K: Investigation of the effects of Propafenone on ventricular arrythmias and signal-averaged ECG parameters.  IXth National Cardiology Congress, 28 September- 1 October 1993, Bursa. Abstract Book, p.:  36, Paper no: 159.
58. Buğra Z, Meriç M, Koylan N, Adalet K, Nişancı Y, Büyüköztürk K, Ertem G: Long-term effects of coronary angioplasty on signal-averaged electrocardiogram.  IXth National Cardiology Congress, 28 September- 1 October 1993, Bursa. Abstract Book, p.:  37, Paper no: 161.
59. Helvacı A, Adalet K, Meriç M, Orak E, Buğra Z, Yılmaz E, Nişancı Y, Koylan N, Umman S, Gören T, Büyüköztürk K, Ertem G: The importance of selective renal angiography along with coronary angiography in hypertensive patients with ischemic heart disease.   IXth National Cardiology Congress, 28 September- 1 October 1993, Bursa. Abstract Book, p.:  64, Paper no: 263.
60. Erzengin F, Mercanoğlu F, Eren N, Orak E, Gören T, Koylan N, Umman B, Öncül A, Büyüköztürk K, Ertem G: New echocardiography diagnosis criteria in hyperthropic heart disease.  IIIrd National Echocardiography Congress, 10-12 May 1994, Antalya Abstract Book, Paper No:  090.
61. Buğra Z, Meriç M, Koylan N, Adalet K, Nişancı Y, Büyüköztürk K, Ertem G: Long-term effects of coronary angioplasty on signal-averaged ECG.  IInd National Invasive Cardiology Congress, 23- 30 June 1994, İzmir. Abstract book, p.48
62. Koylan N, Atılgan D, Canberk A, Buğra Z, Ünlüer O, Vural A, Büyüköztürk K: The signal-averaged ECG findings in patients with mild and moderate essential hypertension.  Xth National Cardiology Congress, 1- 4 October, 1994, İzmir. Abstract Book, paper no:  40.
63. Koylan N, Altuğ T, Atılgan D, Canberk A, Büyüköztürk K: Intracellular free oxygen radicals and signal-averaged ECG in patients with mild and moderate essential hypertension.  Preliminary results. Xth National Cardiology Congress, 1- 4 October, 1994, İzmir. Abstract Book, paper no:  41.
64. Yılmaz E, Nişancı Y, Meriç M, Yılmaz G, Koylan N, Adalet K, Umman S, Gören T, Buğra Z, Öncül A, Büyüköztürk K, Ertem G: The clinical importance of troponin T levels in patients with stable angina pectoris who have underwent percutaneous transluminal coronary angioplasty (a preliminary study).  Xth National Cardiology Congress, 1- 4 October, 1994, İzmir. Abstract Book, paper no:  110.
65. Adalet I, Adalet K, Heper C, Şirali M, Orak E, Buğra Z, Umman B, Koylan N, Cantez S, Büyüköztürk K: Evaluation of the effects of captopril and benazepril on left ventricular functions in patients with essential hypertension using radionuclide ventriculography:   A double-blind comparative study.  Xth National Cardiology Congress, 1- 4 October, 1994, İzmir. Abstract Book, paper no:  118.
66. Koylan N, Canberk A, Gülbaba G, Mercanoğlu F: The effect of nitrendipine on plasma endothelin-I levels in patients with essential hypertension. Xth National Cardiology Congress, 1- 4 October, 1994, İzmir. Abstract Book, paper no:  133.
67. Öncül A, Özsaruhan Ö, Umman S, Nişancı Y, Erzengin F, Koylan N, Meriç M, Büyüköztürk K, Ertem G: Comparison of heart rates obtained with "sensor blending" and "sensor-checking" against normals in patients implanted with dual-chamber dual sensor pacemaker.  Xth National Cardiology Congress, 1- 4 October, 1994, İzmir. Abstract Book, paper no:  157.
68. Öncül A, Özsaruhan Ö, Umman S, Nişancı Y, Adalet K, Koylan N, Umman B, Erzengin F, Meriç M, Büyüköztürk K, Ertem G: The benefits of “sensor blending” and “sensor cross- checking” during daily ordinary activities with multi-sensor dual chamber pacemakers.  Xth National Cardiology Congress, 1- 4 October, 1994, İzmir. Abstract Book, paper no:  158.
69. Koylan N, Okur Ö, Buğra Z, Vural A, Ünlüer O, Büyüköztürk K: Variability in signal-averaged ECG parameters in healthy people.  Xth National Cardiology Congress, 1- 4 October, 1994, İzmir. Abstract Book, paper no:  166.
70. Adalet K, Nalbantgil İ, Kılıççıoğlu B, Koylan N, Buğra Z, Umman B, Adalet I, Erzengin F, Büyüköztürk K: The effects of benazepril and captopril in patients with mild or moderate essential hypertension:  A multi-center, double-blind comparative study.  Xth National Cardiology Congress, 1- 4 October, 1994, İzmir. Abstract Book, paper no:  207.
71. Canberk A, Koylan N, Berkman K, Pakhoo M. The efficacy of sublingual nitrendipine in acute hypertension attacks.  Xth National Cardiology Congress, 1- 4 October, 1994, İzmir. Abstract Book, paper no:  251.
72. Koylan N, Altuğ T, Güzel Ö, Öncül A, Mercanoğlu F, Gündoğdu R, Ertem G: Lipoprotein(a) and other plasma lipid fractions in people with coronary heart disease. Xth National Cardiology Congress, 1- 4 October, 1994, İzmir. Abstract Book, paper no:  270.
73. Koylan N, Pakhoo M, Sezer A, Buğra Z, Mercanoğlu F, Meriç M, Büyüköztürk K: The importance ST – heart rate in the evaluation of the exercise test.  XIth National Cardiology Congress, 23- 26 September, 1995, Istanbul. Abstract book, paper no:  254.
74. Yılmaz E, Ağaçfidan  A, Yılmaz G, Umman B, Mercanoğlu F, Koylan N, Adalet K, Öncül A, Nişancı Y, Meriç M, Büyüköztürk K, Ertem G: Chlamydia pneumoniae infection and coronary heart disease: Can there be a correlation between them? XIth National Cardiology Congress, 23- 26 September, 1995, Istanbul. Abstract book, paper no:  331.

75. Koylan N, Buğra Z, Vural A, Sezer A, Mercanoğlu F, Meriç M, Büyüköztürk K: The acute effects of nisoldipine on left ventricular diastolic function and QT dispersion in patients with mild – moderate hypertension.  
a) XIth National Cardiology Congress, 23- 26 September, 1995, Istanbul. Abstract book, paper no:  366.
b) Çukurova University 1st National Hypertension Congress with International Participation, 19- 21 October 1995, Adana. Congress Book, p.28. 
76. Canberk A, Delier H, Berkman K, Yıldıran G, Koylan N, Büyüköztürk K, Ertem G, Koyuncuoğlu H: Verapamil and trandolapril combination in essential hypertension cases. Çukurova University 1st National Hypertension Congress with International Participation, 19- 21 October 1995, Adana. Congress Book, p.43. 
77. Buğra Z, Koylan N, Vural A, Umman B, Mercanoğlu F, Meriç M, Büyüköztürk K, Ertem G: Types of geometric remodeling and hyperthrophy of the left ventricle and QT dispersion in untreated patients with mild – moderate hypertension.   Turkish Cardiology Society XIIth National Cardiology Congress, Antalya, 16-20 October, 1996. Abstract Book, No 93.
78. Helvacı A, Meriç M, Erzengin F, Koylan N, Gören T, Umman S, Büyüköztürk K, Ertem G: Examination of left atrial appendiceal flows before and after percutaneous mitral valvotomy in patients with mitral stenosis.   Turkish Cardiology Society XIIth National Cardiology Congress, Antalya, 16-20 October, 1996. Abstract Book, No: 281.
79. Mercanoğlu F, Oflaz H, Adalet K, Karşıdağ K, Alo F, Erzengin F, Koylan N, Büyüköztürk K, Ertem G: Left ventricular diastolic functions in normotensive patients with type II diabetes mellitus diagnosed recently.   Turkish Cardiology Society XIIth National Cardiology Congress, Antalya, 16-20 October, 1996. Abstract Book, No: 284.
80. İsbir T, Ağaçkakan B, Yılmaz H, Oflaz H, Koylan N: Examination of ACE gene polymorphism in atherosclerotic and healthy individuals.  Turkish Cardiology Society XIIIth National Cardiology Congress, İzmir, 29 September – 3 October, 1997. Abstract Book, No: 49.
81. Mercanoğlu F, Oflaz H, Nişancı Y, Umman B, Gören T, Meriç M, Erzengin F, Koylan N, Ertem G, Büyüköztürk K: The effects of infarct-related artery patency on early complications, left ventricular functions and revascularization intervention in patients with acute myocardial infaction who recieve thrombolytic therapy.  Turkish Cardiology Society XIIIth National Cardiology Congress, İzmir, 29 September – 3 October, 1997. Abstract Book, No: 100.
82. Mercanoğlu F, Oflaz H, Yılmaz E, Umman B, Gören T, Koylan N, Büyüköztürk K: The value of bed-side quick qualitative troponin- t assay in the diagnosis of acute myocardial infarction.  Turkish Cardiology Society XIIIth National Cardiology Congress, İzmir, 29 September – 3 October, 1997. Abstract Book, No: 188.
83. Oflaz H, Buğra Z, Sezer A, Özaydın M, Koylan N, Büyüköztürk K: The effect of diurnal rhythm on signal-averaged ECG in healthy individuals.   Turkish Cardiology Society XIIIth National Cardiology Congress, İzmir, 29 September – 3 October, 1997. Abstract Book, No: 329.
84. Yılmaz H, Oflaz H, İsbir T, Koylan N: Serum apolipoprotein A1, B and lipoprotein levels in patients diagnosed with atherosclerosis. Turkish Cardiology Society XIIIth National Cardiology Congress, İzmir, 29 September – 3 October, 1997. Abstract Book, No: 395.
85. Koylan N, Taşköprü İ,Karşıdağ K, Oflaz H, Büyüköztürk K: QT dispersion as a new method in the detection of autonomous diabetic neuropathy in patients with non-insuline dependent diabetes mellitus.  XIVth National Cardiology Congress, 10-12 October 1998, Belek, Antalya Paper no: 114.
86. Mercanoğlu F, Oflaz H, Yılmaz E, Umman S, Umman B, Küçükbasmacı Ö, Gören T, Koylan N, Büyüköztürk K: Comparison of qualitative and quantitative troponin T analyses in the diagnosis of acute myocardial infarction.  XIVth National Cardiology Congress, 10-12 October 1998, Belek, Antalya Paper no: 166.
87. Koylan N, Pakhoo M, İspir T, Özbek H, Atılgan D, Meriç M, Büyüköztürk K: The effect of perindopril on erythrocyte membrane ATPase in patients with mild and moderate essential hypertension.  XIVth National Cardiology Congress, 10-12 October 1998, Belek, Antalya Paper no: 217.
88. Atılgan D, Koylan N, Akkaya V, Özbek H, Meriç M, Büyüköztürk K: Does mitral stenosis without atrial fibrillation has a harmful effect on left atrial appendiceal functions? A transesophageal echocardiographic study.  XIVth National Cardiology Congress, 10-12 October 1998, Belek, Antalya Paper no: 297.
89. Koylan N, Büyüköztürk K: Comparison of the effects of trimetazidine and diltiazem on exercise performance in patients with coronary heart disease.  Turkish Trimetazidine Study. XIVth National Cardiology Congress, 10-12 October 1998, Belek, Antalya Paper no: 396.
90. Topbaş A, Koylan N, Oflaz H, Özaydın M, Özsaruhan Ö, Erzengin F: The effect of losartan on plasta prolactin, cortisole and TSH levels in patients with mild and moderate hypertension.  XVth National Cardiology Congress, 9- 12 October 1999, Büyük Efes and Hilton Hotels, İzmir. Subject no: 305.
91. Tayyareci Y, Koylan N, Öncül A, Nisancı Y, Umman B, Altun İ, Yurdakul S, Buğra Z. Presence of insulin resistence in patients with systemic hypertension negatively affects left ventricular systolic functions on a tissue level.   XXIIIrd National Cardiology Congress, 21-24 October 2007, Antalya. Türk Kardiyol Dern Arş 2007, Suppl 2.
92. Tayyareci Y, Beyhan S, Koylan N, Nişancı Y, Öncül A, Altun İ, Adalet K, Buğra Z. The effect of insulin resistence and GGT level on QT dispersion in chronic alcoholic patients.   XXIIIrd National Cardiology Congress, 21-24 October 2007, Antalya. Türk Kardiyol Dern Arş 2007, Suppl 2.
93. Tayyareci Y, Buğra Z, Koylan N, Öncül A, Umman B, Altun İ, Yurdakul S, Adalet K, Nişancı Y. Left ventricular longitudinal functions and contractility are disrupted on a tissue level in patiens with prehypertension. XXIIIrd National Cardiology Congress, 21-24 October 2007, Antalya. Türk Kardiyol Dern Arş 2007, Suppl 2.

Projects with International Acronyms 
1. National Coordinator of HEAAL Study, 2003-2009
2. Member of Executive Board of ICEBERG Epidemyologic Study, 2003-2004
3. Member of International Executive Board of SAGE Study, 1999-2004
4. Member and National Coordinator of International Executive Board of VALUE Study, 1998-2005
5. ELITE II Study (published), 1996- 2000
6. TTS Study (published), 1990- 1996

All Publications Look

Randevu almak artık daha da kolay!

Apple Store ve Google Play Store’dan indireceğiniz Anadolu Sağlık Online Servisler uygulamasıyla işlemlerinizi çok daha hızlı yapabileceksiniz.

Uygulamamızı şimdi indirirseniz anında dilediğiniz doktordan online randevu alabilir, test ve görüntüleme sonuçlarınıza kolayca ulaşabilir ve geçmiş doktor ziyaretlerinizi görüntüleyebilirsiniz.

app store
google play